Summary

Top ## selected# in Chembl# in DrugBank# in Kegg# in any DB
1010 (100%)1 (10%)2 (20%)2 (20%)3 (30%)
2020 (100%)2 (10%)3 (15%)6 (30%)8 (40%)
5050 (100%)5 (10%)5 (10%)7 (14%)12 (24%)
100100 (100%)14 (14%)13 (13%)14 (14%)28 (28%)
200200 (100%)26 (13%)19 (10%)26 (13%)52 (26%)
500500 (100%)50 (10%)36 (7%)58 (12%)107 (21%)
10001000 (100%)69 (7%)62 (6%)93 (9%)171 (17%)

Ranking of Drug—Target Pairs

Rank CH DB KG Drug Target Most Similar Drug Most Similar Target
1NYYNimodipine
CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit0.75000Nitrendipine
0.57786CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
2NNNMetoclopramide
CHRNA5: cholinergic receptor, nicotinic, alpha 50.20000Galantamine hydrobromide
0.44323CHRNA2
3YYNNicotine
CHRNA4: cholinergic receptor, nicotinic, alpha 40.40909Phencyclidine hydrochloride
0.52847CHRNA2
4NNNProparacaine hydrochloride
KCNK5: potassium channel, subfamily K, member 50.66667Procaine hydrochloride
0.013225SCN9A: sodium channel, voltage-gated, type IX, alpha subunit
5NNYBenzocaine
SCN5A: sodium channel, voltage-gated, type V, alpha subunit0.57895Procaine hydrochloride
0.60410SCN10A: sodium channel, voltage-gated, type X, alpha subunit
6NNNRiluzole
GRIK2: glutamate receptor, ionotropic, kainate 20Kainic acid hydrate
0.81064GRIK3: glutamate receptor, ionotropic, kainate 3
7NNNDiazoxide
ABCC9: ATP-binding cassette, sub-family C (CFTR/MRP), member 90.17500Verapamil
0.68192ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 8
8NNNProcainamide hydrochloride
SCN10A: sodium channel, voltage-gated, type X, alpha subunit0.71429Procaine hydrochloride
0.60410SCN5A: sodium channel, voltage-gated, type V, alpha subunit
9NNNPropafenone hydrochloride
SCN10A: sodium channel, voltage-gated, type X, alpha subunit0.45714Disopyramide
0.60410SCN5A: sodium channel, voltage-gated, type V, alpha subunit
10NNNCarbachol
CHRNA1: cholinergic receptor, nicotinic, alpha 1 (muscle)0.35000Hexamethonium bromide
0.46023CHRNA3: cholinergic receptor, nicotinic, alpha 3
11NYYZonisamide
SCN5A: sodium channel, voltage-gated, type V, alpha subunit0.36364Lamotrigine
0.60410SCN10A: sodium channel, voltage-gated, type X, alpha subunit
12NNYGallopamil hydrochloride
CACNA1F: calcium channel, voltage-dependent, L type, alpha 1F subunit0.86486Verapamil
0.56053CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
13NNNSevoflurane
GABRR20.041667Propofol
0.68315GABRR1: gamma-aminobutyric acid (GABA) receptor, rho 1
14NNNIsradipine
CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit0.73333Felodipine
0.28502CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
15NNNCarbachol
CHRNA7: cholinergic receptor, nicotinic, alpha 70.35000Hexamethonium bromide
0.35558CHRNA3: cholinergic receptor, nicotinic, alpha 3
16NNYDiltiazem malate
CACNA1D: calcium channel, voltage-dependent, L type, alpha 1D subunit0.35791Amlodipine maleate
0.64082CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
17NNNTrifluoperazine hydrochloride
KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 30.87879Fluphenazine hydrochloride
0.62986KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
18NNYDiltiazem hydrochloride
CACNA1D: calcium channel, voltage-dependent, L type, alpha 1D subunit0.40425Nicardipine hydrochloride
0.64082CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
19NNNHaloperidol
GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A0.30303Ketamine hydrochloride
0.44349GRIN3B: glutamate receptor, ionotropic, N-methyl-D-aspartate 3B
20YNNClozapine
HTR3C0.37143Ondansetron hydrochloride hydrate
0.73813HTR3E: 5-hydroxytryptamine (serotonin) receptor 3, family member E
21NNNPropofol
GLRA30.20690Tropisetron hydrochloride
0.83309GLRA1: glycine receptor, alpha 1
22NNNMexiletine hydrochloride
SCN10A: sodium channel, voltage-gated, type X, alpha subunit0.52381Lidocaine hydrochloride
0.60410SCN5A: sodium channel, voltage-gated, type V, alpha subunit
23NNNProcainamide hydrochloride
KCNK5: potassium channel, subfamily K, member 50.71429Procaine hydrochloride
0.013225SCN9A: sodium channel, voltage-gated, type IX, alpha subunit
24NNNPentobarbital
CHRNA1: cholinergic receptor, nicotinic, alpha 1 (muscle)0.16129Metoclopramide
0.46023CHRNA3: cholinergic receptor, nicotinic, alpha 3
25NNNDiazepam
GLRA30.35484Tropisetron hydrochloride
0.83309GLRA1: glycine receptor, alpha 1
26YNNSumatriptan
HTR3C0.28000Dopamine hydrochloride
0.73813HTR3E: 5-hydroxytryptamine (serotonin) receptor 3, family member E
27NNNParamethadione
CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit0.75000Trimethadione
0.44753CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
28NNNPindolol
HTR3C0.27273Granisetron hydrochloride
0.73813HTR3E: 5-hydroxytryptamine (serotonin) receptor 3, family member E
29NNNNimodipine
CACNA2D1: calcium channel, voltage-dependent, alpha 2/delta subunit 10.75000Nitrendipine
0.19447CACNA2D4: calcium channel, voltage-dependent, alpha 2/delta subunit 4
30NNNIsoflurane
GLRA2: glycine receptor, alpha 20.57143Sevoflurane
0.76918GLRA1: glycine receptor, alpha 1
31NYYVerapamil hydrochloride
CACNA1F: calcium channel, voltage-dependent, L type, alpha 1F subunit0.97059Verapamil
0.56053CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
32NNNCarbachol
CHRNA5: cholinergic receptor, nicotinic, alpha 50.35000Hexamethonium bromide
0.44323CHRNA2
33YNNNicotine
CHRNA1: cholinergic receptor, nicotinic, alpha 1 (muscle)0.40909Phencyclidine hydrochloride
0.46023CHRNA3: cholinergic receptor, nicotinic, alpha 3
34NNNTocainide hydrochloride
SCN10A: sodium channel, voltage-gated, type X, alpha subunit0.68421Prilocaine hydrochloride
0.60410SCN5A: sodium channel, voltage-gated, type V, alpha subunit
35NNNGlyclopyramide
KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 10.73913Tolazamide
0.39373KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11
36NNNGliclazide
KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 10.79167Tolazamide
0.39373KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11
37NNNTrifluoperazine maleate
KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 30.74468Fluphenazine maleate
0.62986KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
38NNNVerapamil
KCNK2: potassium channel, subfamily K, member 20.40909Dofetilide
0.51272KCNK10: potassium channel, subfamily K, member 10
39NNNVerapamil
SCN11A: sodium channel, voltage-gated, type XI, alpha subunit0.12245Cocaine
0.47691SCN10A: sodium channel, voltage-gated, type X, alpha subunit
40NNNEncainide hydrochloride
SCN10A: sodium channel, voltage-gated, type X, alpha subunit0.53333Mepivacaine hydrochloride
0.60410SCN5A: sodium channel, voltage-gated, type V, alpha subunit
41NNNVerapamil
ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 80.29412Glyburide
0.68192ABCC9: ATP-binding cassette, sub-family C (CFTR/MRP), member 9
42NNNEncainide hydrochloride
KCNK5: potassium channel, subfamily K, member 50.53333Mepivacaine hydrochloride
0.013225SCN9A: sodium channel, voltage-gated, type IX, alpha subunit
43NNNHalothane
KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)0.66667Methoxyflurane
0.048992KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
44NNNMoricizine hydrochloride
SCN10A: sodium channel, voltage-gated, type X, alpha subunit0.43243Dyclonine hydrochloride
0.60410SCN5A: sodium channel, voltage-gated, type V, alpha subunit
45NNNFelbamate
GLRA30.25806Tropisetron hydrochloride
0.83309GLRA1: glycine receptor, alpha 1
46NNNTocainide hydrochloride
KCNK5: potassium channel, subfamily K, member 50.68421Prilocaine hydrochloride
0.013225SCN9A: sodium channel, voltage-gated, type IX, alpha subunit
47NNNAmoxapine
SLC6A3: solute carrier family 6 (neurotransmitter transporter, dopamine), member 30.55556Mazindol
0.68182SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
48NNNNimodipine
CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit0.75000Nitrendipine
0.28399CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
49NNNFlecainide acetate
KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 30.25532Quinine hydrochloride hydrate
0.66887KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 2
50YYNNicotine
CHRNA7: cholinergic receptor, nicotinic, alpha 70.40909Phencyclidine hydrochloride
0.35558CHRNA3: cholinergic receptor, nicotinic, alpha 3
51NNYGallopamil hydrochloride
CACNA1D: calcium channel, voltage-dependent, L type, alpha 1D subunit0.86486Verapamil
0.64082CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
52NNNIsoflurane
GLRB0.57143Sevoflurane
0.38089GLRA1: glycine receptor, alpha 1
53NYNPentobarbital
CHRNA7: cholinergic receptor, nicotinic, alpha 70.16129Metoclopramide
0.35558CHRNA3: cholinergic receptor, nicotinic, alpha 3
54YNYGranisetron
HTR3B: 5-hydroxytryptamine (serotonin) receptor 3B0.95833Granisetron hydrochloride
0.40524HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A
55NNNTrimethadione
CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit0.75000Paramethadione
0.44753CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit
56YNYMetoclopramide
HTR3C0.28000Dopamine hydrochloride
0.73813HTR3E: 5-hydroxytryptamine (serotonin) receptor 3, family member E
57NNNFluphenazine maleate
KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 20.74468Trifluoperazine maleate
0.62986KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
58NNNFluphenazine hydrochloride
KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 20.87879Trifluoperazine hydrochloride
0.62986KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
59NNNCaffeine
CFTR: cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49)0.93333Caffeine hydrate
0.014488P2RX6: purinergic receptor P2X, ligand-gated ion channel, 6
60NNNAcetohexamide
KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 110.72000Tolazamide
0.39373KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
61NNNVerapamil
KCNK12: potassium channel, subfamily K, member 120.052632Halothane
0.61540KCNK13: potassium channel, subfamily K, member 13
62NNNSevoflurane
GLRA30.030303Tropisetron hydrochloride
0.83309GLRA1: glycine receptor, alpha 1
63NNNPentobarbital
CHRNA5: cholinergic receptor, nicotinic, alpha 50.16000Mecamylamine hydrochloride
0.44323CHRNA2
64NNNDiazoxide
KCNK2: potassium channel, subfamily K, member 20.22857Dofetilide
0.51272KCNK10: potassium channel, subfamily K, member 10
65NNNAmiloride hydrochloride
CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit0.14286Zonisamide
0.47136CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit
66NYNTrimipramine
SLC6A3: solute carrier family 6 (neurotransmitter transporter, dopamine), member 30.35484Mazindol
0.68182SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
67NNNFlecainide acetate
SCN10A: sodium channel, voltage-gated, type X, alpha subunit0.38461Dyclonine hydrochloride
0.60410SCN5A: sodium channel, voltage-gated, type V, alpha subunit
68NNNDantrolene
RYR30.31250Phenytoin
0.66763RYR1: ryanodine receptor 1 (skeletal)
69NNNDantrolene
RYR2: ryanodine receptor 2 (cardiac)0.31250Phenytoin
0.66507RYR1: ryanodine receptor 1 (skeletal)
70NNNMoricizine hydrochloride
KCNK5: potassium channel, subfamily K, member 50.43243Dyclonine hydrochloride
0.013225SCN9A: sodium channel, voltage-gated, type IX, alpha subunit
71NNNNortriptyline hydrochloride
KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 20.86957Amitriptyline hydrochloride
0.62986KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
72YNNClozapine
HTR3D: 5-hydroxytryptamine (serotonin) receptor 3 family member D0.37143Ondansetron hydrochloride hydrate
0.50844HTR3E: 5-hydroxytryptamine (serotonin) receptor 3, family member E
73YNYGranisetron
HTR3E: 5-hydroxytryptamine (serotonin) receptor 3, family member E0.95833Granisetron hydrochloride
0.31879HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A
74NNNAmiloride hydrochloride
SCN4B0.26923Riluzole
0.025789ACCN1: amiloride-sensitive cation channel 1, neuronal
75NNNMexiletine hydrochloride
KCNK5: potassium channel, subfamily K, member 50.52381Lidocaine hydrochloride
0.013225SCN9A: sodium channel, voltage-gated, type IX, alpha subunit
76NNNChlorpromazine hibenzate
KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 10.36364Dequalinium chloride
0.63878KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
77NNNEtomidate
GABRR20.36667Zaleplon
0.68315GABRR1: gamma-aminobutyric acid (GABA) receptor, rho 1
78YNNLamotrigine
SCN10A: sodium channel, voltage-gated, type X, alpha subunit0.40909Riluzole
0.60410SCN5A: sodium channel, voltage-gated, type V, alpha subunit
79NYNAlprazolam
GABRR20.68000Diazepam
0.68315GABRR1: gamma-aminobutyric acid (GABA) receptor, rho 1
80NYNFlurazepam
GABRR20.62069Diazepam
0.68315GABRR1: gamma-aminobutyric acid (GABA) receptor, rho 1
81NYNNicotine
CHRNA5: cholinergic receptor, nicotinic, alpha 50.40909Phencyclidine hydrochloride
0.44323CHRNA2
82YYNMethylphenidate
SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 40.56000Cocaine
0.49354SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
83NNNAmiloride hydrochloride
SCN7A: sodium channel, voltage-gated, type VII, alpha0.26923Riluzole
0.087772CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit
84YNNSumatriptan
HTR3D: 5-hydroxytryptamine (serotonin) receptor 3 family member D0.28000Dopamine hydrochloride
0.50844HTR3E: 5-hydroxytryptamine (serotonin) receptor 3, family member E
85YNYOndansetron
HTR3B: 5-hydroxytryptamine (serotonin) receptor 3B0.88000Ondansetron hydrochloride hydrate
0.40524HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A
86NNNPindolol
HTR3D: 5-hydroxytryptamine (serotonin) receptor 3 family member D0.27273Granisetron hydrochloride
0.50844HTR3E: 5-hydroxytryptamine (serotonin) receptor 3, family member E
87YYYMazindol
SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 40.55556Amoxapine
0.49354SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
88NNNCyproheptadine hydrochloride
KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 30.37500Chlorpromazine hibenzate
0.62986KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
89NNNChlorpromazine phenolphthalinate
KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 10.30645Dequalinium chloride
0.63878KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
90NNNDesipramine hydrochloride
KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 20.72000Amitriptyline hydrochloride
0.62986KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
91NNNQuinidine gluconate
SCN10A: sodium channel, voltage-gated, type X, alpha subunit0.25532Levobupivacaine hydrochloride
0.60410SCN5A: sodium channel, voltage-gated, type V, alpha subunit
92NNNAmiloride hydrochloride
SCN1B: sodium channel, voltage-gated, type I, beta0.26923Riluzole
0.024163ACCN3: amiloride-sensitive cation channel 3
93NNNVerapamil hydrochloride
KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 20.97059Verapamil
0.66887KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
94NNNTropisetron hydrochloride
GLRB0.35484Diazepam
0.39983GLRA3
95NNNAmiloride hydrochloride
SCN3B: sodium channel, voltage-gated, type III, beta0.26923Riluzole
0.024794ACCN1: amiloride-sensitive cation channel 1, neuronal
96NNNBethanidine sulfate
SLC6A3: solute carrier family 6 (neurotransmitter transporter, dopamine), member 30.25714Phentermine
0.68182SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
97NNNPentobarbital
GABRR20.16000Propofol
0.68315GABRR1: gamma-aminobutyric acid (GABA) receptor, rho 1
98NYYZonisamide
SCN2A: sodium channel, voltage-gated, type II, alpha subunit0.36364Lamotrigine
0.87680SCN1A: sodium channel, voltage-gated, type I, alpha subunit
99NNNLevetiracetam
CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit0.29412Ethosuximide
0.48256CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit
100NNNCaffeine
KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 40.93333Caffeine hydrate
0.021666P2RX4: purinergic receptor P2X, ligand-gated ion channel, 4
101NNNFlecainide acetate
KCNA4: potassium voltage-gated channel, shaker-related subfamily, member 40.27778Quinidine gluconate
0.58884KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
102NNNAmitriptyline hydrochloride
KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 10.41935Fluoxetine
0.63878KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
103NNNQuinidine sulfate
SCN10A: sodium channel, voltage-gated, type X, alpha subunit0.20548Verapamil
0.60410SCN5A: sodium channel, voltage-gated, type V, alpha subunit
104NNNDiltiazem malate
KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 70.33962Verapamil
0.59825KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
105NNNMaprotiline
SLC6A3: solute carrier family 6 (neurotransmitter transporter, dopamine), member 30.41379Mazindol
0.68182SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
106YNYOndansetron
HTR3E: 5-hydroxytryptamine (serotonin) receptor 3, family member E0.88000Ondansetron hydrochloride hydrate
0.31879HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A
107NNNVerapamil hydrochloride
KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)0.97059Verapamil
0.66583KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
108NNNVerapamil hydrochloride
KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 50.97059Verapamil
0.53491KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
109NYNMidazolam
GABRR20.59259Diazepam
0.68315GABRR1: gamma-aminobutyric acid (GABA) receptor, rho 1
110NNNPhenytoin
GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A0.37500Dizocilpine maleate
0.022827SCN4B
111NNNVerapamil
GRIA3: glutamate receptor, ionotrophic, AMPA 30.20000Riluzole
0.026689KCNE1: potassium voltage-gated channel, Isk-related family, member 1
112YNNSertraline
SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 20.57692Maprotiline
0.49354SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
113NNNDiltiazem hydrochloride
KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 70.39130Verapamil hydrochloride
0.59825KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
114NNNVerapamil
GRIA4: glutamate receptor, ionotrophic, AMPA 40.20000Riluzole
0.026577KCNE1: potassium voltage-gated channel, Isk-related family, member 1
115NYYVerapamil hydrochloride
CACNA1D: calcium channel, voltage-dependent, L type, alpha 1D subunit0.97059Verapamil
0.64082CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
116NNNParamethadione
CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit0.40000Ethosuximide
0.47136CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
117NNNFlecainide acetate
KCNK5: potassium channel, subfamily K, member 50.38461Dyclonine hydrochloride
0.030801KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
118NNNTrimethadione
CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit0.33333Ethosuximide
0.48256CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit
119NNNQuinidine sulfate
KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 31Quinine sulfate
0.56382KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
120NNNDiazoxide
KCNK12: potassium channel, subfamily K, member 120.050000Halothane
0.61540KCNK13: potassium channel, subfamily K, member 13
121NNNGallopamil hydrochloride
KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 30.89189Verapamil hydrochloride
0.021436CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
122NNNBenoxinate hydrochloride
SCN5A: sodium channel, voltage-gated, type V, alpha subunit0.80000Proparacaine hydrochloride
0.60410SCN10A: sodium channel, voltage-gated, type X, alpha subunit
123NNNIsoflurane
GABRR20.095238Propofol
0.68315GABRR1: gamma-aminobutyric acid (GABA) receptor, rho 1
124NNNDofetilide
KCNH1: potassium voltage-gated channel, subfamily H (eag-related), member 10.40909Verapamil
0.74648KCNH5: potassium voltage-gated channel, subfamily H (eag-related), member 5
125NNNPromethazine hydrochloride
KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 20.65385Amitriptyline hydrochloride
0.62986KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
126NNNLevetiracetam
CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit0.29412Ethosuximide
0.44753CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit
127NNNGabapentin
SCN1A: sodium channel, voltage-gated, type I, alpha subunit0.26316Levetiracetam
0.83065SCN3A: sodium channel, voltage-gated, type III, alpha subunit
128YNNVerapamil
SCN2A: sodium channel, voltage-gated, type II, alpha subunit0.34091Propafenone hydrochloride
0.86296SCN3A: sodium channel, voltage-gated, type III, alpha subunit
129NNNMibefradil dihydrochloride
CACNA1B: calcium channel, voltage-dependent, N type, alpha 1B subunit0.44898Verapamil
0.58498CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
130NNNGuanadrel sulfate
SLC6A3: solute carrier family 6 (neurotransmitter transporter, dopamine), member 30.083333Methylphenidate
0.68182SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
131NNNDequalinium chloride
KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 30.42500Desipramine hydrochloride
0.55275KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1
132NNNDequalinium chloride
KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 20.41463Amitriptyline hydrochloride
0.63878KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1
133NNNCarbachol
CHRND: cholinergic receptor, nicotinic, delta0.29167Metoclopramide
0.42466CHRNE: cholinergic receptor, nicotinic, epsilon
134NNNPromethazine teoclate
KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 20.43590Amitriptyline hydrochloride
0.62986KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
135NNNGuanethidine sulfate
SLC6A3: solute carrier family 6 (neurotransmitter transporter, dopamine), member 30.086957Methylphenidate
0.68182SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
136NNNIbutilide fumarate
CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit0.30667Diltiazem malate
0.57786CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
137NNNZaleplon
GLRB0.30303Diazepam
0.29609GABRB1
138NNNVerapamil
SCN9A: sodium channel, voltage-gated, type IX, alpha subunit0.34091Propafenone hydrochloride
0.75410SCN3A: sodium channel, voltage-gated, type III, alpha subunit
139NNNMibefradil dihydrochloride
CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit0.46939Verapamil hydrochloride
0.29326CACNA1E: calcium channel, voltage-dependent, R type, alpha 1E subunit
140NNNMaprotiline
SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 40.57692Sertraline
0.49354SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
141NNYMirtazapine
HTR3B: 5-hydroxytryptamine (serotonin) receptor 3B0.53571Clozapine
0.40524HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A
142NNYPrilocaine
SCN10A: sodium channel, voltage-gated, type X, alpha subunit0.94118Prilocaine hydrochloride
0.60410SCN5A: sodium channel, voltage-gated, type V, alpha subunit
143NNYDiazoxide
KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 110.32000Glyclopyramide
0.66902KCNJ8: potassium inwardly-rectifying channel, subfamily J, member 8
144NNNVerapamil
ACCN1: amiloride-sensitive cation channel 1, neuronal0.085106Amiloride hydrochloride
0.48895ACCN3: amiloride-sensitive cation channel 3
145YNNVerapamil
SCN8A: sodium channel, voltage gated, type VIII, alpha subunit0.34091Propafenone hydrochloride
0.72659SCN3A: sodium channel, voltage-gated, type III, alpha subunit
146NNYDisopyramide
SCN1A: sodium channel, voltage-gated, type I, alpha subunit0.45714Propafenone hydrochloride
0.83065SCN3A: sodium channel, voltage-gated, type III, alpha subunit
147NYYZonisamide
SCN9A: sodium channel, voltage-gated, type IX, alpha subunit0.36364Lamotrigine
0.76982SCN1A: sodium channel, voltage-gated, type I, alpha subunit
148NNNMethylphenidate
SLC6A1: solute carrier family 6 (neurotransmitter transporter, GABA), member 10.56000Cocaine
0.44420SLC6A3: solute carrier family 6 (neurotransmitter transporter, dopamine), member 3
149NNNFlecainide acetate
KCNA6: potassium voltage-gated channel, shaker-related subfamily, member 60.20370Verapamil
0.60832KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 2
150NNNLamotrigine
KCNK5: potassium channel, subfamily K, member 50.30435Diazoxide
0.013225SCN9A: sodium channel, voltage-gated, type IX, alpha subunit
151NNNVerapamil
KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 110.29167Ibutilide fumarate
0.66902KCNJ8: potassium inwardly-rectifying channel, subfamily J, member 8
152YNYBenzocaine
SCN1A: sodium channel, voltage-gated, type I, alpha subunit0.57895Procaine hydrochloride
0.83065SCN3A: sodium channel, voltage-gated, type III, alpha subunit
153NNNVerapamil
ACCN2: amiloride-sensitive cation channel 2, neuronal0.085106Amiloride hydrochloride
0.47336ACCN3: amiloride-sensitive cation channel 3
154NNNCocaine
SLC6A7: solute carrier family 6 (neurotransmitter transporter, L-proline), member 70.11111Proline
0.42834SLC6A1: solute carrier family 6 (neurotransmitter transporter, GABA), member 1
155NNNGlimepiride
KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 110.58537Glipizide
0.39373KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
156YNNVerapamil
SCN1A: sodium channel, voltage-gated, type I, alpha subunit0.34091Propafenone hydrochloride
0.83065SCN3A: sodium channel, voltage-gated, type III, alpha subunit
157YNNTubocurarine chloride
KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 30.28169Chlorpromazine hibenzate
0.62986KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
158NNNEthotoin
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.72222Primidone
0.0092349SCN5A: sodium channel, voltage-gated, type V, alpha subunit
159NNNGallopamil hydrochloride
CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit0.86486Verapamil
0.28502CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
160NNNPentobarbital
CHRND: cholinergic receptor, nicotinic, delta0.16129Metoclopramide
0.42466CHRNE: cholinergic receptor, nicotinic, epsilon
161NNNCarbachol
CHRNB1: cholinergic receptor, nicotinic, beta 1 (muscle)0.29167Metoclopramide
0.37214CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)
162NNNIsradipine
CACNA2D3: calcium channel, voltage-dependent, alpha 2/delta subunit 30.66667Nisoldipine
0.61055CACNA2D4: calcium channel, voltage-dependent, alpha 2/delta subunit 4
163NNNGallopamil hydrochloride
KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 60.89189Verapamil hydrochloride
0.012103CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
164NNNDiazoxide
GRID2: glutamate receptor, ionotropic, delta 20.38095Riluzole
0.19653GRIA2: glutamate receptor, ionotropic, AMPA 2
165NYNPhentermine
SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 40.32000Cocaine
0.49354SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
166YNNNicotine
CHRND: cholinergic receptor, nicotinic, delta0.14286Metoclopramide
0.42466CHRNE: cholinergic receptor, nicotinic, epsilon
167YYNParoxetine
SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 20.48387Amoxapine
0.49354SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
168NNNEtomidate
GLRA1: glycine receptor, alpha 10.40000Felbamate
0.32784GABRA2: gamma-aminobutyric acid (GABA) A receptor, alpha 2
169NNNRiluzole
SCN1A: sodium channel, voltage-gated, type I, alpha subunit0.40909Lamotrigine
0.83065SCN3A: sodium channel, voltage-gated, type III, alpha subunit
170NNYZonisamide
SCN8A: sodium channel, voltage gated, type VIII, alpha subunit0.36364Lamotrigine
0.75242SCN1A: sodium channel, voltage-gated, type I, alpha subunit
171NNNVerapamil hydrochloride
KCNC1: potassium voltage-gated channel, Shaw-related subfamily, member 10.97059Verapamil
0.63973KCNC2: potassium voltage-gated channel, Shaw-related subfamily, member 2
172NNYTolbutamide
KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 110.56000Tolazamide
0.39373KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
173NNNIsradipine
CACNB1: calcium channel, voltage-dependent, beta 1 subunit0.66667Nisoldipine
0.56271CACNB2: calcium channel, voltage-dependent, beta 2 subunit
174NNNIbutilide fumarate
CACNB2: calcium channel, voltage-dependent, beta 2 subunit0.29167Verapamil
0.56271CACNB1: calcium channel, voltage-dependent, beta 1 subunit
175NNNGallopamil hydrochloride
KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 70.89189Verapamil hydrochloride
0.022438CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
176NNNDoxorubicin hydrochloride
CFTR: cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49)0.23729Glyburide
0.0043818RYR2: ryanodine receptor 2 (cardiac)
177NNNPentobarbital
CHRNB1: cholinergic receptor, nicotinic, beta 1 (muscle)0.16129Metoclopramide
0.37214CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)
178NNNDiltiazem hydrochloride
KCNA6: potassium voltage-gated channel, shaker-related subfamily, member 60.36956Verapamil
0.60832KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 2
179NNNPhenacemide
SCN5A: sodium channel, voltage-gated, type V, alpha subunit0.42105Tocainide
0.60301SCN1A: sodium channel, voltage-gated, type I, alpha subunit
180YNNNicotine
HTR3B: 5-hydroxytryptamine (serotonin) receptor 3B0.36000Tropisetron hydrochloride
0.40524HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A
181YNYCarbamazepine
SCN1A: sodium channel, voltage-gated, type I, alpha subunit0.40000Moricizine hydrochloride
0.83065SCN3A: sodium channel, voltage-gated, type III, alpha subunit
182NNNDiltiazem hydrochloride
KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 100.39130Verapamil hydrochloride
0.58819KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
183NNNDiltiazem malate
KCNA6: potassium voltage-gated channel, shaker-related subfamily, member 60.33962Verapamil
0.60832KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 2
184NNNFlecainide acetate
KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 100.28302Ketoconazole
0.58819KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
185YNNNicotine
CHRNB1: cholinergic receptor, nicotinic, beta 1 (muscle)0.14286Metoclopramide
0.37214CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)
186NNNVerapamil hydrochloride
KCNA4: potassium voltage-gated channel, shaker-related subfamily, member 40.97059Verapamil
0.54817KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
187NNNQuinine sulfate
KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 71Quinidine sulfate
0.56382KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
188NNNDiltiazem malate
KCNA4: potassium voltage-gated channel, shaker-related subfamily, member 40.33962Verapamil
0.58884KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
189NNNKainic acid hydrate
GRID2: glutamate receptor, ionotropic, delta 20Riluzole
0.20292GRIK2: glutamate receptor, ionotropic, kainate 2
190NNNFurosemide
KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 10.51613Benzthiazide
0.011447GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
191NNNMibefradil dihydrochloride
CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit0.46939Verapamil hydrochloride
0.28734CACNA1E: calcium channel, voltage-dependent, R type, alpha 1E subunit
192NNNCocaine
SLC6A14: solute carrier family 6 (amino acid transporter), member 140.11111Proline
0.38828SLC6A1: solute carrier family 6 (neurotransmitter transporter, GABA), member 1
193NNNTrifluoperazine hydrochloride
KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 10.51429Fluoxetine hydrochloride
0.63878KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
194NNNVerapamil
GRIA2: glutamate receptor, ionotropic, AMPA 20.20000Riluzole
0.027448KCNE1: potassium voltage-gated channel, Isk-related family, member 1
195NNNDiltiazem hydrochloride
KCNA4: potassium voltage-gated channel, shaker-related subfamily, member 40.40425Nicardipine hydrochloride
0.58884KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
196NYNIsradipine
CACNA2D2: calcium channel, voltage-dependent, alpha 2/delta subunit 20.66667Nisoldipine
0.52208CACNA2D1: calcium channel, voltage-dependent, alpha 2/delta subunit 1
197NNNCyproheptadine hydrochloride
KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 10.39317Tubocurarine chloride
0.63878KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
198NNYTopiramate
GRIK3: glutamate receptor, ionotropic, kainate 30.15152Kainic acid hydrate
0.72331GRIK1: glutamate receptor, ionotropic, kainate 1
199NNNProfenamine hydrochloride
KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 30.76000Promethazine hydrochloride
0.013549GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A
200NNNGabapentin
SCN11A: sodium channel, voltage-gated, type XI, alpha subunit0.096774Cocaine
0.47691SCN10A: sodium channel, voltage-gated, type X, alpha subunit
201NNNGabapentin
SCN2A: sodium channel, voltage-gated, type II, alpha subunit0.25926Dyclonine hydrochloride
0.86296SCN3A: sodium channel, voltage-gated, type III, alpha subunit
202NNNDiltiazem malate
CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit0.38182Mibefradil dihydrochloride
0.28502CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
203NNNQuinine sulfate
KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 51Quinidine sulfate
0.53491KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
204YNYGranisetron
HTR3C0.95833Granisetron hydrochloride
0.31377HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A
205NNNIsradipine
CACNA1E: calcium channel, voltage-dependent, R type, alpha 1E subunit0.66667Nisoldipine
0.29326CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
206NNNDoxorubicin hydrochloride
KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 40.24624Ketoconazole
0.0071212RYR2: ryanodine receptor 2 (cardiac)
207NNNPhenytoin
SCN11A: sodium channel, voltage-gated, type XI, alpha subunit0.17143Cocaine
0.47691SCN10A: sodium channel, voltage-gated, type X, alpha subunit
208NNNStreptomycin sulfate
CFTR: cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49)0.066667Glyburide
0.0043818RYR2: ryanodine receptor 2 (cardiac)
209NNNQuinidine gluconate
KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 20.31579Diltiazem malate
0.58845KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
210NNNVerapamil
MCOLN1: mucolipin 10.085106Amiloride hydrochloride
0.032255KCNE2: potassium voltage-gated channel, Isk-related family, member 2
211NYNMagnesium sulfate
CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit0.062500Amlodipine besylate
0.57786CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
212YNNRiluzole
SCN2A: sodium channel, voltage-gated, type II, alpha subunit0.40909Lamotrigine
0.86296SCN3A: sodium channel, voltage-gated, type III, alpha subunit
213NNYAcetohexamide
ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 80.61765Glyburide
0.013742KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
214NNYGlyburide
KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 110.77778Glipizide
0.39373KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
215NNNNimodipine
CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit0.75000Nitrendipine
0.12954CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
216NNNZaleplon
GLRA2: glycine receptor, alpha 20.30303Diazepam
0.32569GABRD: gamma-aminobutyric acid (GABA) A receptor, delta
217NNNHaloperidol
KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 60.42492Thioridazine hydrochloride
0.015023GRIN2C: glutamate receptor, ionotropic, N-methyl D-aspartate 2C
218NNNDiltiazem malate
KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 100.33962Verapamil
0.58819KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
219NNNHalothane
RYR2: ryanodine receptor 2 (cardiac)0.078947Pimozide
0.021708ITPR3: inositol 1,4,5-trisphosphate receptor, type 3
220YNYMetoclopramide
HTR3D: 5-hydroxytryptamine (serotonin) receptor 3 family member D0.28000Dopamine hydrochloride
0.50844HTR3E: 5-hydroxytryptamine (serotonin) receptor 3, family member E
221NNYDibucaine
SCN4A: sodium channel, voltage-gated, type IV, alpha subunit0.48276Procainamide hydrochloride
0.58238SCN5A: sodium channel, voltage-gated, type V, alpha subunit
222NNNVerapamil
TRPC6: transient receptor potential cation channel, subfamily C, member 60.085106Amiloride hydrochloride
0.027859KCNS2: potassium voltage-gated channel, delayed-rectifier, subfamily S, member 2
223NNNCarbachol
HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A0.29167Metoclopramide
0.26265CHRNA10
224NNNHalothane
RYR30.078947Pimozide
0.021825ITPR3: inositol 1,4,5-trisphosphate receptor, type 3
225NNNRiluzole
SCN11A: sodium channel, voltage-gated, type XI, alpha subunit0.12121Cocaine
0.47691SCN10A: sodium channel, voltage-gated, type X, alpha subunit
226NNYMirtazapine
HTR3E: 5-hydroxytryptamine (serotonin) receptor 3, family member E0.53571Clozapine
0.31879HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A
227NNYCocaine
SCN4A: sodium channel, voltage-gated, type IV, alpha subunit0.36000Benzocaine
0.58238SCN5A: sodium channel, voltage-gated, type V, alpha subunit
228NNNRiluzole
KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 10.45833Hydroflumethiazide
0.016547SCN1B: sodium channel, voltage-gated, type I, beta
229NNNEthosuximide
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.47059Butabarbital
0.011438CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
230NNNGallopamil hydrochloride
KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 100.89189Verapamil hydrochloride
0.022185CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
231NNNMibefradil dihydrochloride
CACNA1D: calcium channel, voltage-dependent, L type, alpha 1D subunit0.44898Verapamil
0.27185CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
232NNNIbutilide fumarate
KCNH5: potassium voltage-gated channel, subfamily H (eag-related), member 50.41270Dofetilide
0.27171KCNH6: potassium voltage-gated channel, subfamily H (eag-related), member 6
233NNNIbutilide fumarate
CACNA1F: calcium channel, voltage-dependent, L type, alpha 1F subunit0.30667Diltiazem malate
0.56053CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
234NNNDofetilide
KCNH7: potassium voltage-gated channel, subfamily H (eag-related), member 70.41270Ibutilide fumarate
0.52729KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2
235NNYTopiramate
GRIK2: glutamate receptor, ionotropic, kainate 20.15152Kainic acid hydrate
0.76835GRIK1: glutamate receptor, ionotropic, kainate 1
236NNNDofetilide
KCNH6: potassium voltage-gated channel, subfamily H (eag-related), member 60.41270Ibutilide fumarate
0.50037KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2
237NNNQuinine sulfate
KCNA4: potassium voltage-gated channel, shaker-related subfamily, member 41Quinidine sulfate
0.54817KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
238NNNNimodipine
CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit0.75000Nitrendipine
0.11063CACNA1F: calcium channel, voltage-dependent, L type, alpha 1F subunit
239NNNPropafenone hydrochloride
KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 70.45000Amiodarone hydrochloride
0.51877KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5
240NNNGranisetron hydrochloride
GLRA30.53333Tropisetron hydrochloride
0.095753HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A
241NNNEtomidate
GLRB0.40000Felbamate
0.29609GABRB1
242NNNPenfluridol
CACNA1E: calcium channel, voltage-dependent, R type, alpha 1E subunit0.64729Pimozide
0.12631CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
243YNYGranisetron
HTR3D: 5-hydroxytryptamine (serotonin) receptor 3 family member D0.95833Granisetron hydrochloride
0.16111HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A
244NNNPhentermine
SLC6A1: solute carrier family 6 (neurotransmitter transporter, GABA), member 10.32000Cocaine
0.44420SLC6A3: solute carrier family 6 (neurotransmitter transporter, dopamine), member 3
245NNNDiltiazem hydrochloride
CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit0.44681Mibefradil dihydrochloride
0.28502CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
246NNNTrimipramine
KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 30.72000Promethazine hydrochloride
0.017087SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
247YYYPhenytoin
SCN1A: sodium channel, voltage-gated, type I, alpha subunit0.36364Propafenone hydrochloride
0.83065SCN3A: sodium channel, voltage-gated, type III, alpha subunit
248NNNFelodipine
CACNG1: calcium channel, voltage-dependent, gamma subunit 10.75862Nitrendipine
0.018083CACNA1F: calcium channel, voltage-dependent, L type, alpha 1F subunit
249NNNMagnesium sulfate
CACNA1D: calcium channel, voltage-dependent, L type, alpha 1D subunit0.062500Amlodipine besylate
0.64082CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
250NNNMibefradil dihydrochloride
CACNA1F: calcium channel, voltage-dependent, L type, alpha 1F subunit0.44898Verapamil
0.27364CACNA1E: calcium channel, voltage-dependent, R type, alpha 1E subunit
251NNNVerapamil hydrochloride
KCNA6: potassium voltage-gated channel, shaker-related subfamily, member 60.97059Verapamil
0.57211KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
252NNNGabapentin
SCN9A: sodium channel, voltage-gated, type IX, alpha subunit0.25926Dyclonine hydrochloride
0.75410SCN3A: sodium channel, voltage-gated, type III, alpha subunit
253NNNEtomidate
GLRA2: glycine receptor, alpha 20.40000Felbamate
0.32569GABRD: gamma-aminobutyric acid (GABA) A receptor, delta
254NNNLevobupivacaine hydrochloride
KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 50.95652Bupivacaine hydrochloride
0.026637KCNK5: potassium channel, subfamily K, member 5
255NNNKainic acid hydrate
GRIA3: glutamate receptor, ionotrophic, AMPA 30.034483Diazoxide
0.35489GRIK2: glutamate receptor, ionotropic, kainate 2
256NNNVerapamil
CLCN2: chloride channel 20.11111Lubiprostone
0.022598KCNE2: potassium voltage-gated channel, Isk-related family, member 2
257NNNNimodipine
CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit0.75000Nitrendipine
0.10257CACNA1F: calcium channel, voltage-dependent, L type, alpha 1F subunit
258NNNQuinidine sulfate
KCNB2: potassium voltage-gated channel, Shab-related subfamily, member 21Quinine sulfate
0.20403KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
259NNYTopiramate
SCN2A: sodium channel, voltage-gated, type II, alpha subunit0.20000Mexiletine hydrochloride
0.87680SCN1A: sodium channel, voltage-gated, type I, alpha subunit
260NNNLevetiracetam
SCN2A: sodium channel, voltage-gated, type II, alpha subunit0.30769Dyclonine hydrochloride
0.87680SCN1A: sodium channel, voltage-gated, type I, alpha subunit
261NNNRiluzole
SCN9A: sodium channel, voltage-gated, type IX, alpha subunit0.40909Lamotrigine
0.75410SCN3A: sodium channel, voltage-gated, type III, alpha subunit
262NNNVerapamil
CFTR: cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49)0.29412Glyburide
0.15287ABCC9: ATP-binding cassette, sub-family C (CFTR/MRP), member 9
263NNNKainic acid hydrate
GRIA4: glutamate receptor, ionotrophic, AMPA 40.034483Diazoxide
0.34506GRIK2: glutamate receptor, ionotropic, kainate 2
264NNNTrifluoperazine hydrochloride
KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 60.64706Thioridazine hydrochloride
0.030674KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
265NNNGallopamil hydrochloride
KCNC2: potassium voltage-gated channel, Shaw-related subfamily, member 20.89189Verapamil hydrochloride
0.022846CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
266NNNMagnesium sulfate
CACNA1F: calcium channel, voltage-dependent, L type, alpha 1F subunit0.062500Amlodipine besylate
0.56053CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
267YNNNicotine
HTR3E: 5-hydroxytryptamine (serotonin) receptor 3, family member E0.36000Tropisetron hydrochloride
0.31879HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A
268NNNAminoglutethimide
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.57143Primidone
0.090264CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)
269NNNFelodipine
CACNA2D4: calcium channel, voltage-dependent, alpha 2/delta subunit 40.75862Nitrendipine
0.0092209CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
270NNNEnflurane
GLRA2: glycine receptor, alpha 20.46667Sevoflurane
0.76918GLRA1: glycine receptor, alpha 1
271NYNFelodipine
CACNB2: calcium channel, voltage-dependent, beta 2 subunit0.75862Nitrendipine
0.017211CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
272NNNGabapentin
SCN8A: sodium channel, voltage gated, type VIII, alpha subunit0.25926Dyclonine hydrochloride
0.72659SCN3A: sodium channel, voltage-gated, type III, alpha subunit
273YNYPhenytoin
SCN2A: sodium channel, voltage-gated, type II, alpha subunit0.36364Propafenone hydrochloride
0.86296SCN3A: sodium channel, voltage-gated, type III, alpha subunit
274YNYDibucaine
SCN3A: sodium channel, voltage-gated, type III, alpha subunit0.48276Procainamide hydrochloride
0.60341SCN5A: sodium channel, voltage-gated, type V, alpha subunit
275NNNTrifluoperazine maleate
KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 10.34694Fluoxetine
0.63878KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
276YNYCocaine
SCN3A: sodium channel, voltage-gated, type III, alpha subunit0.36000Benzocaine
0.60341SCN5A: sodium channel, voltage-gated, type V, alpha subunit
277NNNNateglinide
KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 110.45161Gliclazide
0.39373KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
278NNNQuinidine gluconate
KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 30.60000Quinine hydrochloride hydrate
0.56382KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
279NYYGlipizide
ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 80.77778Glyburide
0.013742KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
280NNNZaleplon
GLRA1: glycine receptor, alpha 10.30303Diazepam
0.32784GABRA2: gamma-aminobutyric acid (GABA) A receptor, alpha 2
281NNNStreptomycin sulfate
KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 40.075630Verapamil
0.0071212RYR2: ryanodine receptor 2 (cardiac)
282NYNVerapamil hydrochloride
KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 20.97059Verapamil
0.023050KCNC2: potassium voltage-gated channel, Shaw-related subfamily, member 2
283NNNRiluzole
SCN8A: sodium channel, voltage gated, type VIII, alpha subunit0.40909Lamotrigine
0.72659SCN3A: sodium channel, voltage-gated, type III, alpha subunit
284NNNPentobarbital
GLRB0.16000Propofol
0.29609GABRB1
285NNNMethoxyflurane
GLRA2: glycine receptor, alpha 20.33333Sevoflurane
0.76918GLRA1: glycine receptor, alpha 1
286NNNDofetilide
KCNK10: potassium channel, subfamily K, member 100.40909Verapamil
0.51272KCNK2: potassium channel, subfamily K, member 2
287NNNIbutilide fumarate
CACNA1D: calcium channel, voltage-dependent, L type, alpha 1D subunit0.29167Verapamil
0.64082CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
288NNNPropofol
GRIA1: glutamate receptor, ionotropic, AMPA 10.22727Diazoxide
0.018959GLRA1: glycine receptor, alpha 1
289NNNButabarbital
CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)0.82353Pentobarbital
0.090264GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
290NNNNicardipine hydrochloride
CACNA1E: calcium channel, voltage-dependent, R type, alpha 1E subunit0.67568Nitrendipine
0.51802CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
291NNNThioridazine hydrochloride
KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 30.56757Fluphenazine hydrochloride
0.024221KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
292NNNMazindol
SLC6A1: solute carrier family 6 (neurotransmitter transporter, GABA), member 10.20000Cocaine
0.44420SLC6A3: solute carrier family 6 (neurotransmitter transporter, dopamine), member 3
293NNNKainic acid hydrate
GRIA2: glutamate receptor, ionotropic, AMPA 20.11111Cyclothiazide
0.36035GRIK2: glutamate receptor, ionotropic, kainate 2
294YNNTubocurarine chloride
CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)0.21311Letrozole
0.44784CHRNA2
295NNNQuinidine sulfate
KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 20.20779Diltiazem malate
0.58845KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
296NNNAminoglutethimide
CHRNE: cholinergic receptor, nicotinic, epsilon0.32000Pentobarbital
0.31850CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)
297NNNFelbamate
GABRR20.20000Propofol
0.29902GLRA2: glycine receptor, alpha 2
298NNNMetocurine iodide
KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 20.67619Tubocurarine chloride
0.018097CHRNA2
299NNNPhenacemide
SCN2A: sodium channel, voltage-gated, type II, alpha subunit0.40000Tocainide hydrochloride
0.87680SCN1A: sodium channel, voltage-gated, type I, alpha subunit
300NNNIbutilide fumarate
KCNH1: potassium voltage-gated channel, subfamily H (eag-related), member 10.29167Verapamil
0.28151KCNH6: potassium voltage-gated channel, subfamily H (eag-related), member 6
301NNNHalothane
RYR1: ryanodine receptor 1 (skeletal)0.078947Pimozide
0.021654ITPR1: inositol 1,4,5-trisphosphate receptor, type 1
302NNNCaffeine hydrate
P2RX4: purinergic receptor P2X, ligand-gated ion channel, 40.93333Caffeine
0.021666KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
303NNNNicardipine hydrochloride
CACNG1: calcium channel, voltage-dependent, gamma subunit 10.67568Nitrendipine
0.019066KCNA4: potassium voltage-gated channel, shaker-related subfamily, member 4
304NYNVerapamil hydrochloride
CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit0.97059Verapamil
0.28502CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
305NNYPhenytoin
SCN9A: sodium channel, voltage-gated, type IX, alpha subunit0.36364Propafenone hydrochloride
0.75410SCN3A: sodium channel, voltage-gated, type III, alpha subunit
306NNNTrimipramine
SLC6A1: solute carrier family 6 (neurotransmitter transporter, GABA), member 10.25714Cocaine
0.43128SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
307NNNRopivacaine hydrochloride
KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 50.87500Bupivacaine hydrochloride
0.026637KCNK5: potassium channel, subfamily K, member 5
308NNNExemestane
CHRNA20.27273Dextromethorphan
0.44784CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)
309NNNDextromethorphan
SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 20.37037Methylphenidate
0.49354SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
310NNNKetamine hydrochloride
KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 60.38710Thioridazine hydrochloride
0.024001GABRA6: gamma-aminobutyric acid (GABA) A receptor, alpha 6
311NNNCaffeine hydrate
P2RX1: purinergic receptor P2X, ligand-gated ion channel, 10.93333Caffeine
0.019059KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
312NYNNimodipine
CACNB1: calcium channel, voltage-dependent, beta 1 subunit0.75000Nitrendipine
0.56271CACNB2: calcium channel, voltage-dependent, beta 2 subunit
313YNNTubocurarine chloride
GABRG2: gamma-aminobutyric acid (GABA) A receptor, gamma 20.23975Midazolam
0.43368GABRA6: gamma-aminobutyric acid (GABA) A receptor, alpha 6
314YNYOndansetron
HTR3C0.88000Ondansetron hydrochloride hydrate
0.31377HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A
315NNNAmlodipine besylate
CACNA1E: calcium channel, voltage-dependent, R type, alpha 1E subunit0.48837Nitrendipine
0.51802CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
316NNNCaffeine hydrate
P2RX3: purinergic receptor P2X, ligand-gated ion channel, 30.93333Caffeine
0.016400KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
317NNNCaffeine hydrate
P2RX5: purinergic receptor P2X, ligand-gated ion channel, 50.93333Caffeine
0.019642KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
318NNNCaffeine hydrate
P2RX6: purinergic receptor P2X, ligand-gated ion channel, 60.93333Caffeine
0.015356KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
319NNNQuinine hydrochloride hydrate
KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 50.60000Quinidine gluconate
0.53491KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
320NNYOxcarbazepine
SCN4A: sodium channel, voltage-gated, type IV, alpha subunit0.76191Carbamazepine
0.58238SCN5A: sodium channel, voltage-gated, type V, alpha subunit
321NNNQuinidine gluconate
KCNK4: potassium channel, subfamily K, member 40.18644Verapamil
0.38351KCNK2: potassium channel, subfamily K, member 2
322NNNAmoxapine
SLC6A1: solute carrier family 6 (neurotransmitter transporter, GABA), member 10.22222Cocaine
0.43128SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
323NNNOxcarbazepine
SCN10A: sodium channel, voltage-gated, type X, alpha subunit0.76191Carbamazepine
0.60410SCN5A: sodium channel, voltage-gated, type V, alpha subunit
324NNNIbutilide fumarate
CACNA2D2: calcium channel, voltage-dependent, alpha 2/delta subunit 20.29167Verapamil
0.52208CACNA2D1: calcium channel, voltage-dependent, alpha 2/delta subunit 1
325NNNHalothane
GLRA2: glycine receptor, alpha 20.46154Sevoflurane
0.76918GLRA1: glycine receptor, alpha 1
326NYNQuinidine gluconate
KCNK1: potassium channel, subfamily K, member 10.21250Ibutilide fumarate
0.38862KCNK6: potassium channel, subfamily K, member 6
327NNNDiazoxide
GRIK5: glutamate receptor, ionotropic, kainate 50.38095Riluzole
0.29524GRIA3: glutamate receptor, ionotrophic, AMPA 3
328NNNDesflurane
GLRA2: glycine receptor, alpha 20.57143Sevoflurane
0.76918GLRA1: glycine receptor, alpha 1
329NNNPropofol
KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)0.26471Diltiazem hydrochloride
0.019626GABRD: gamma-aminobutyric acid (GABA) A receptor, delta
330NYYGlimepiride
ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 80.55814Glyburide
0.013742KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
331NNNProline
SLC6A1: solute carrier family 6 (neurotransmitter transporter, GABA), member 10.11111Cocaine
0.42834SLC6A7: solute carrier family 6 (neurotransmitter transporter, L-proline), member 7
332NNYMecamylamine hydrochloride
CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)0.20690Exemestane
0.44784CHRNA2
333NYNNicardipine hydrochloride
CACNB2: calcium channel, voltage-dependent, beta 2 subunit0.67568Nitrendipine
0.021060KCNA4: potassium voltage-gated channel, shaker-related subfamily, member 4
334NNYTocainide
SCN1A: sodium channel, voltage-gated, type I, alpha subunit0.93333Tocainide hydrochloride
0.60301SCN5A: sodium channel, voltage-gated, type V, alpha subunit
335NNNNicardipine hydrochloride
CACNA1B: calcium channel, voltage-dependent, N type, alpha 1B subunit0.67568Nitrendipine
0.58498CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
336NNNMagnesium sulfate
CACNA2D4: calcium channel, voltage-dependent, alpha 2/delta subunit 40.027027Nifedipine
0.19447CACNA2D1: calcium channel, voltage-dependent, alpha 2/delta subunit 1
337NNNCaffeine hydrate
P2RX7: purinergic receptor P2X, ligand-gated ion channel, 70.93333Caffeine
0.013336KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
338NNNIsradipine
CACNA1B: calcium channel, voltage-dependent, N type, alpha 1B subunit0.66667Nisoldipine
0.29050CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
339NNNNimodipine
CACNA2D3: calcium channel, voltage-dependent, alpha 2/delta subunit 30.75000Nitrendipine
0.61055CACNA2D4: calcium channel, voltage-dependent, alpha 2/delta subunit 4
340NNNCaffeine hydrate
P2RX2: purinergic receptor P2X, ligand-gated ion channel, 20.93333Caffeine
0.017000KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
341NNNDiazoxide
GRIK4: glutamate receptor, ionotropic, kainate 40.38095Riluzole
0.29011GRIA1: glutamate receptor, ionotropic, AMPA 1
342NNNIsradipine
CACNB4: calcium channel, voltage-dependent, beta 4 subunit0.66667Nisoldipine
0.54913CACNB2: calcium channel, voltage-dependent, beta 2 subunit
343NNNParamethadione
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.30435Methohexital
0.011438CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
344NNNDesflurane
KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 20.23529Flecainide acetate
0.79208KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
345NNNMaprotiline
KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 30.68000Desipramine hydrochloride
0.017087SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
346NYNAmlodipine besylate
CACNA1B: calcium channel, voltage-dependent, N type, alpha 1B subunit0.48837Nitrendipine
0.58498CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
347YNYPhenytoin
SCN8A: sodium channel, voltage gated, type VIII, alpha subunit0.36364Propafenone hydrochloride
0.72659SCN3A: sodium channel, voltage-gated, type III, alpha subunit
348NNNDiazoxide
GRIK3: glutamate receptor, ionotropic, kainate 30.38095Riluzole
0.34712GRIA2: glutamate receptor, ionotropic, AMPA 2
349NNNVerapamil hydrochloride
KCNB2: potassium voltage-gated channel, Shab-related subfamily, member 20.97059Verapamil
0.20857KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 10
350YYNGlyburide
ABCC9: ATP-binding cassette, sub-family C (CFTR/MRP), member 90.29412Verapamil
0.68192ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 8
351NNNNicardipine hydrochloride
CACNA2D4: calcium channel, voltage-dependent, alpha 2/delta subunit 40.67568Nitrendipine
0.010062KCNA4: potassium voltage-gated channel, shaker-related subfamily, member 4
352NNNQuinidine sulfate
KCNK4: potassium channel, subfamily K, member 40.20548Verapamil
0.38351KCNK2: potassium channel, subfamily K, member 2
353NNNQuinidine sulfate
SCN7A: sodium channel, voltage-gated, type VII, alpha0.20548Verapamil
0.48453SCN9A: sodium channel, voltage-gated, type IX, alpha subunit
354NNNVerapamil
CHRND: cholinergic receptor, nicotinic, delta0.29268Metoclopramide
0.029958KCNE3: potassium voltage-gated channel, Isk-related family, member 3
355NNNDiazoxide
GRIK2: glutamate receptor, ionotropic, kainate 20.034483Kainic acid hydrate
0.36035GRIA2: glutamate receptor, ionotropic, AMPA 2
356NNNLevetiracetam
SCN9A: sodium channel, voltage-gated, type IX, alpha subunit0.30769Dyclonine hydrochloride
0.76982SCN1A: sodium channel, voltage-gated, type I, alpha subunit
357NNNBethanidine sulfate
SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 40.30952Trimipramine
0.49354SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
358NNNQuinine sulfate
KCNK2: potassium channel, subfamily K, member 21Quinidine sulfate
0.034129KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
359NNNVerapamil hydrochloride
KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 30.97059Verapamil
0.029136KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 10
360NNNVerapamil
GRID2: glutamate receptor, ionotropic, delta 20.20000Riluzole
0.020345KCNE1L: KCNE1-like
361NNNAlprazolam
GLRA1: glycine receptor, alpha 10.68000Diazepam
0.32784GABRA2: gamma-aminobutyric acid (GABA) A receptor, alpha 2
362NNNMetocurine iodide
CHRNA4: cholinergic receptor, nicotinic, alpha 40.67619Tubocurarine chloride
0.52847CHRNA2
363NNNDofetilide
KCNK6: potassium channel, subfamily K, member 60.41270Ibutilide fumarate
0.19314KCNK2: potassium channel, subfamily K, member 2
364NNYHexamethonium bromide
CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)0.35000Carbachol
0.44784CHRNA2
365NNNMoricizine hydrochloride
KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 50.52632Loratadine
0.016875SCN4A: sodium channel, voltage-gated, type IV, alpha subunit
366NNNMetocurine iodide
CHRNA3: cholinergic receptor, nicotinic, alpha 30.67619Tubocurarine chloride
0.52424CHRNA2
367NNNFlurazepam
GLRB0.62069Diazepam
0.29609GABRB1
368NNNLevetiracetam
SCN8A: sodium channel, voltage gated, type VIII, alpha subunit0.30769Dyclonine hydrochloride
0.75242SCN1A: sodium channel, voltage-gated, type I, alpha subunit
369NNNVerapamil
P2RX2: purinergic receptor P2X, ligand-gated ion channel, 20.17500Caffeine
0.042682KCNK4: potassium channel, subfamily K, member 4
370NNNDiazoxide
CFTR: cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49)0.27027Glyburide
0.14579ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 8
371NNNFlecainide acetate
GRIA1: glutamate receptor, ionotropic, AMPA 10.27027Riluzole
0.015652KCNC1: potassium voltage-gated channel, Shaw-related subfamily, member 1
372NNYTopiramate
SCN9A: sodium channel, voltage-gated, type IX, alpha subunit0.20000Mexiletine hydrochloride
0.76982SCN1A: sodium channel, voltage-gated, type I, alpha subunit
373NNNAlprazolam
GLRB0.68000Diazepam
0.29609GABRB1
374NNNVerapamil
CHRNB1: cholinergic receptor, nicotinic, beta 1 (muscle)0.29268Metoclopramide
0.035142KCNK4: potassium channel, subfamily K, member 4
375NNNIndapamide
KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 10.42857Benzthiazide
0.022575KCNQ1: potassium voltage-gated channel, KQT-like subfamily, member 1
376NNNAmlexanox
CFTR: cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49)0.38235Caffeine and sodium benzoate
0.14579ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 8
377NNNQuinine sulfate
KCNH5: potassium voltage-gated channel, subfamily H (eag-related), member 51Quinidine sulfate
0.015687KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
378NNNBupivacaine hydrochloride
KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 70.34146Flecainide acetate
0.51877KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5
379NNNPenfluridol
CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit0.64729Pimozide
0.11362CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
380NNYDisopyramide
SCN2A: sodium channel, voltage-gated, type II, alpha subunit0.45714Propafenone hydrochloride
0.86296SCN3A: sodium channel, voltage-gated, type III, alpha subunit
381NNNTolbutamide
CFTR: cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49)0.41667Glyburide
0.14579ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 8
382NNYTopiramate
SCN8A: sodium channel, voltage gated, type VIII, alpha subunit0.20000Mexiletine hydrochloride
0.75242SCN1A: sodium channel, voltage-gated, type I, alpha subunit
383NNNIsoflurane
GLRA30.032258Tropisetron hydrochloride
0.83309GLRA1: glycine receptor, alpha 1
384NNYOxcarbazepine
SCN3A: sodium channel, voltage-gated, type III, alpha subunit0.76191Carbamazepine
0.60341SCN5A: sodium channel, voltage-gated, type V, alpha subunit
385NNNPentobarbital
GLRA1: glycine receptor, alpha 10.16000Propofol
0.32784GABRA2: gamma-aminobutyric acid (GABA) A receptor, alpha 2
386NNNLevetiracetam
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.26087Ketamine hydrochloride
0.0099594SCN1A: sodium channel, voltage-gated, type I, alpha subunit
387NNNNortriptyline hydrochloride
KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 10.48276Fluoxetine
0.55275KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
388NNNIsradipine
CACNB3: calcium channel, voltage-dependent, beta 3 subunit0.66667Nisoldipine
0.48563CACNB2: calcium channel, voltage-dependent, beta 2 subunit
389YNYOndansetron
HTR3D: 5-hydroxytryptamine (serotonin) receptor 3 family member D0.88000Ondansetron hydrochloride hydrate
0.16111HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A
390NNNAmitriptyline hydrochloride
KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 60.50000Thioridazine hydrochloride
0.030674KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
391NNNDiazoxide
CLCN2: chloride channel 20.051282Lubiprostone
0.022598KCNE2: potassium voltage-gated channel, Isk-related family, member 2
392NNNVerapamil
SLC6A14: solute carrier family 6 (amino acid transporter), member 140Proline
0.033290KCNK17: potassium channel, subfamily K, member 17
393NNNQuinidine gluconate
KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)0.31579Diltiazem malate
0.59825KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
394NNNIbutilide fumarate
CACNA2D4: calcium channel, voltage-dependent, alpha 2/delta subunit 40.29167Verapamil
0.19447CACNA2D1: calcium channel, voltage-dependent, alpha 2/delta subunit 1
395NNNGuanadrel sulfate
SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 40.17021Dextromethorphan
0.49354SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
396NNNAnastrozole
CHRNE: cholinergic receptor, nicotinic, epsilon0.23529Metoclopramide
0.31850CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)
397NNNEthosuximide
CACNA1E: calcium channel, voltage-dependent, R type, alpha 1E subunit0.15790Gabapentin
0.12631CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
398NNNIbutilide fumarate
CACNB4: calcium channel, voltage-dependent, beta 4 subunit0.29167Verapamil
0.56963CACNB1: calcium channel, voltage-dependent, beta 1 subunit
399NNNAmlexanox
KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 10.37500Repaglinide
0.013742ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 8
400NNNDesipramine hydrochloride
KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 10.48276Fluoxetine
0.55275KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
401NNNVerapamil
SLC6A7: solute carrier family 6 (neurotransmitter transporter, L-proline), member 70Proline
0.031499KCNK16: potassium channel, subfamily K, member 16
402NYNQuinidine sulfate
KCNK1: potassium channel, subfamily K, member 10.20548Verapamil
0.38862KCNK6: potassium channel, subfamily K, member 6
403NNNGallopamil hydrochloride
KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 20.86486Verapamil
0.0095753CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
404NNNIsradipine
PKD1: polycystic kidney disease 1 (autosomal dominant)0.66667Nisoldipine
0.0092008CACNG1: calcium channel, voltage-dependent, gamma subunit 1
405NNNEnflurane
KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 20.20000Flecainide acetate
0.79208KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
406NNNPhenacemide
SCN3A: sodium channel, voltage-gated, type III, alpha subunit0.40000Tocainide hydrochloride
0.83065SCN1A: sodium channel, voltage-gated, type I, alpha subunit
407NNNQuinine sulfate
KCNK10: potassium channel, subfamily K, member 101Quinidine sulfate
0.029311KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
408NNNRiluzole
ACCN2: amiloride-sensitive cation channel 2, neuronal0.26923Amiloride hydrochloride
0.47336ACCN3: amiloride-sensitive cation channel 3
409NNNQuinidine gluconate
SCN7A: sodium channel, voltage-gated, type VII, alpha0.19231Disopyramide
0.48453SCN9A: sodium channel, voltage-gated, type IX, alpha subunit
410NNNEncainide hydrochloride
KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 50.47059Bupivacaine hydrochloride
0.016875SCN4A: sodium channel, voltage-gated, type IV, alpha subunit
411NNNHalothane
GLRA30.035714Tropisetron hydrochloride
0.83309GLRA1: glycine receptor, alpha 1
412NNNRiluzole
ACCN1: amiloride-sensitive cation channel 1, neuronal0.26923Amiloride hydrochloride
0.48895ACCN3: amiloride-sensitive cation channel 3
413NNNTrimipramine
SCN5A: sodium channel, voltage-gated, type V, alpha subunit0.51852Oxcarbazepine
0.013973SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
414NNNRiluzole
GRIN3B: glutamate receptor, ionotropic, N-methyl-D-aspartate 3B0.23077Ketamine hydrochloride
0.44349GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A
415NNNQuinine sulfate
KCNK6: potassium channel, subfamily K, member 61Quinidine sulfate
0.041460KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
416NNNPrilocaine
SCN4A: sodium channel, voltage-gated, type IV, alpha subunit0.94118Prilocaine hydrochloride
0.58238SCN5A: sodium channel, voltage-gated, type V, alpha subunit
417NNNVerapamil
GLRA30.14583Tropisetron hydrochloride
0.029733KCNE1L: KCNE1-like
418NNNFlurazepam
GLRA1: glycine receptor, alpha 10.62069Diazepam
0.32784GABRA2: gamma-aminobutyric acid (GABA) A receptor, alpha 2
419NNNVerapamil hydrochloride
KCNC4: potassium voltage-gated channel, Shaw-related subfamily, member 40.97059Verapamil
0.63607KCNC2: potassium voltage-gated channel, Shaw-related subfamily, member 2
420NNNFelodipine
CACNA1E: calcium channel, voltage-dependent, R type, alpha 1E subunit0.75862Nitrendipine
0.51802CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
421NNNPenfluridol
KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 20.48936Astemizole
0.013728CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit
422YNYPrilocaine
SCN1A: sodium channel, voltage-gated, type I, alpha subunit0.94118Prilocaine hydrochloride
0.60301SCN5A: sodium channel, voltage-gated, type V, alpha subunit
423NNNPhencyclidine hydrochloride
CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)0.40909Nicotine
0.44784CHRNA2
424NNNMetocurine iodide
CHRNA6: cholinergic receptor, nicotinic, alpha 60.67619Tubocurarine chloride
0.49191CHRNA2
425NNNQuinine sulfate
KCNK16: potassium channel, subfamily K, member 161Quinidine sulfate
0.033222KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
426NNNMitiglinide calcium hydrate
KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 10.30909Nateglinide
0.39373KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11
427YNNTubocurarine chloride
GABRG30.23975Midazolam
0.40101GABRA6: gamma-aminobutyric acid (GABA) A receptor, alpha 6
428NNNMidazolam
GLRA1: glycine receptor, alpha 10.59259Diazepam
0.32784GABRA2: gamma-aminobutyric acid (GABA) A receptor, alpha 2
429NNNKetamine hydrochloride
GABRG2: gamma-aminobutyric acid (GABA) A receptor, gamma 20.37500Flurazepam
0.43368GABRA6: gamma-aminobutyric acid (GABA) A receptor, alpha 6
430YYNPimozide
KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 20.65854Astemizole
0.017111CACNB2: calcium channel, voltage-dependent, beta 2 subunit
431NNNPhenacemide
SCN9A: sodium channel, voltage-gated, type IX, alpha subunit0.40000Tocainide hydrochloride
0.76982SCN1A: sodium channel, voltage-gated, type I, alpha subunit
432NNNLubiprostone
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.25926Penicillin G procaine
0.013899CLCN2: chloride channel 2
433NNNVerapamil
SLC6A1: solute carrier family 6 (neurotransmitter transporter, GABA), member 10.12245Cocaine
0.033720CACNG1: calcium channel, voltage-dependent, gamma subunit 1
434NNNQuinine sulfate
KCNH1: potassium voltage-gated channel, subfamily H (eag-related), member 11Quinidine sulfate
0.016688KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
435NNNHexamethonium bromide
CHRNE: cholinergic receptor, nicotinic, epsilon0.35000Carbachol
0.31221CHRNA3: cholinergic receptor, nicotinic, alpha 3
436NNNPentobarbital
GLRA2: glycine receptor, alpha 20.16000Propofol
0.32569GABRD: gamma-aminobutyric acid (GABA) A receptor, delta
437NNNPhenacemide
SCN8A: sodium channel, voltage gated, type VIII, alpha subunit0.40000Tocainide hydrochloride
0.75242SCN1A: sodium channel, voltage-gated, type I, alpha subunit
438NYNNicotine bitartrate
CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)0.35294Nicotine
0.44784CHRNA2
439NNNQuinidine sulfate
KCNA6: potassium voltage-gated channel, shaker-related subfamily, member 60.20548Verapamil
0.57211KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
440NNNDiazoxide
MCOLN1: mucolipin 10.18518Amiloride hydrochloride
0.032255KCNE2: potassium voltage-gated channel, Isk-related family, member 2
441NNNEthotoin
SCN10A: sodium channel, voltage-gated, type X, alpha subunit0.36000Phenytoin
0.60410SCN5A: sodium channel, voltage-gated, type V, alpha subunit
442NNNFelodipine
CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit0.75862Nitrendipine
0.13350CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
443NNNAmlexanox
ABCC9: ATP-binding cassette, sub-family C (CFTR/MRP), member 90.27907Verapamil
0.68192ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 8
444NNNProcaine hydrochloride
SCN7A: sodium channel, voltage-gated, type VII, alpha0.57895Benzocaine
0.48453SCN9A: sodium channel, voltage-gated, type IX, alpha subunit
445NNNDiazoxide
TRPC6: transient receptor potential cation channel, subfamily C, member 60.18518Amiloride hydrochloride
0.027859KCNS2: potassium voltage-gated channel, delayed-rectifier, subfamily S, member 2
446NNNProline
SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 20.19048Methylphenidate
0.41013SLC6A7: solute carrier family 6 (neurotransmitter transporter, L-proline), member 7
447NNNFelodipine
CACNA1B: calcium channel, voltage-dependent, N type, alpha 1B subunit0.75862Nitrendipine
0.58498CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
448YNNHaloperidol
KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 20.52632Cisapride
0.014090GRIN2C: glutamate receptor, ionotropic, N-methyl D-aspartate 2C
449NNNQuinidine sulfate
SCN11A: sodium channel, voltage-gated, type XI, alpha subunit0.16667Cocaine
0.46734SCN5A: sodium channel, voltage-gated, type V, alpha subunit
450NNNGlipizide
CFTR: cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49)0.77778Glyburide
0.014445KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
451NNNPropafenone hydrochloride
KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 20.34091Verapamil
0.55968KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5
452NNNMethoxyflurane
KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 20.17647Flecainide acetate
0.79208KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
453YNNDextromethorphan
GRIN3B: glutamate receptor, ionotropic, N-methyl-D-aspartate 3B0.42308Ketamine hydrochloride
0.44349GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A
454NNNAmiodarone hydrochloride
SCN5A: sodium channel, voltage-gated, type V, alpha subunit0.58333Dibucaine
0.025844KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
455NNNQuinidine gluconate
KCNA6: potassium voltage-gated channel, shaker-related subfamily, member 60.18644Verapamil
0.57211KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
456NNNDopamine hydrochloride
GLRA30.21429Tropisetron hydrochloride
0.095753HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A
457NYNAmlodipine maleate
CACNA1B: calcium channel, voltage-dependent, N type, alpha 1B subunit0.48837Nisoldipine
0.58498CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
458NNNLevetiracetam
SCN5A: sodium channel, voltage-gated, type V, alpha subunit0.30769Dyclonine hydrochloride
0.60301SCN1A: sodium channel, voltage-gated, type I, alpha subunit
459NNNLevobupivacaine hydrochloride
KCND3: potassium voltage-gated channel, Shal-related subfamily, member 30.95652Bupivacaine hydrochloride
0.027135KCNK5: potassium channel, subfamily K, member 5
460NYNButabarbital
GABRA2: gamma-aminobutyric acid (GABA) A receptor, alpha 20.82353Pentobarbital
0.74880GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
461NNNFluphenazine hydrochloride
KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 10.44737Fluoxetine hydrochloride
0.55275KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
462NNNVerapamil
P2RX7: purinergic receptor P2X, ligand-gated ion channel, 70.17500Caffeine
0.027427KCNE2: potassium voltage-gated channel, Isk-related family, member 2
463NNNNicotine bitartrate
KCND2: potassium voltage-gated channel, Shal-related subfamily, member 20.11628Diazoxide
0.74853KCND3: potassium voltage-gated channel, Shal-related subfamily, member 3
464NNNGuanethidine sulfate
SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 40.17778Dextromethorphan
0.49354SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
465NNNSevoflurane
KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 20.25714Flecainide acetate
0.79208KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
466NNNOndansetron hydrochloride hydrate
GLRA30.34286Tropisetron hydrochloride
0.095753HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A
467NNNQuinidine sulfate
KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 100.31884Ketoconazole
0.54502KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
468NNNTrifluoperazine maleate
KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 60.45833Thioridazine hydrochloride
0.030674KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
469NNNThioridazine
KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 30.54054Fluphenazine hydrochloride
0.024221KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
470NNNBenzocaine
CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit0.31034Nitrendipine
0.12677SCN3A: sodium channel, voltage-gated, type III, alpha subunit
471NNNDiltiazem hydrochloride
KCNC2: potassium voltage-gated channel, Shaw-related subfamily, member 20.39130Verapamil hydrochloride
0.63973KCNC1: potassium voltage-gated channel, Shaw-related subfamily, member 1
472NNNMetocurine iodide
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.67619Tubocurarine chloride
0.077681CHRNA2
473NNNIbutilide fumarate
KCNJ8: potassium inwardly-rectifying channel, subfamily J, member 80.29167Verapamil
0.66902KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11
474NNNBenzocaine
CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit0.31034Nitrendipine
0.12915SCN3A: sodium channel, voltage-gated, type III, alpha subunit
475NNNAmlodipine maleate
CACNA1E: calcium channel, voltage-dependent, R type, alpha 1E subunit0.48837Nisoldipine
0.51802CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
476NNNGranisetron hydrochloride
GLRA2: glycine receptor, alpha 20.53333Tropisetron hydrochloride
0.10113HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A
477NNNProline
SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 40.16667Dextromethorphan
0.38489SLC6A7: solute carrier family 6 (neurotransmitter transporter, L-proline), member 7
478NNNDiazoxide
GRIK1: glutamate receptor, ionotropic, kainate 10.38095Riluzole
0.34713GRIA1: glutamate receptor, ionotropic, AMPA 1
479NNNTrimethadione
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.28571Hexobarbital
0.0087226CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit
480YNNCyclothiazide
GRIA4: glutamate receptor, ionotrophic, AMPA 40.26667Diazoxide
0.73920GRIA2: glutamate receptor, ionotropic, AMPA 2
481NNNQuinidine gluconate
KCNK17: potassium channel, subfamily K, member 170.18644Verapamil
0.34803KCNK16: potassium channel, subfamily K, member 16
482NNNTropisetron hydrochloride
GABRR20.35484Diazepam
0.29902GLRA2: glycine receptor, alpha 2
483YNYCarbamazepine
SCN2A: sodium channel, voltage-gated, type II, alpha subunit0.40000Moricizine hydrochloride
0.86296SCN3A: sodium channel, voltage-gated, type III, alpha subunit
484NNYMecamylamine hydrochloride
CHRNE: cholinergic receptor, nicotinic, epsilon0.20000Carbachol
0.31221CHRNA3: cholinergic receptor, nicotinic, alpha 3
485NNNTerfenadine
KCNH7: potassium voltage-gated channel, subfamily H (eag-related), member 70.27114Verapamil
0.52729KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2
486NNNDantrolene
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.41935Clobazam
0.0064074RYR1: ryanodine receptor 1 (skeletal)
487NNNCetiedil citrate
CFTR: cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49)0.20690Glyburide
0.010929KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
488NNNFlecainide acetate
SCN7A: sodium channel, voltage-gated, type VII, alpha0.27027Riluzole
0.48453SCN9A: sodium channel, voltage-gated, type IX, alpha subunit
489NNNVerapamil hydrochloride
SCN4A: sodium channel, voltage-gated, type IV, alpha subunit0.97059Verapamil
0.14611CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
490NNNDisopyramide
CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit0.34884Verapamil
0.13120SCN5A: sodium channel, voltage-gated, type V, alpha subunit
491YNYTocainide
SCN4A: sodium channel, voltage-gated, type IV, alpha subunit0.93333Tocainide hydrochloride
0.58238SCN5A: sodium channel, voltage-gated, type V, alpha subunit
492NNNKetoconazole
CFTR: cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49)0.40816Glyburide
0.011075KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 10
493NNNLevobupivacaine hydrochloride
KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 60.95652Bupivacaine hydrochloride
0.021715KCNK5: potassium channel, subfamily K, member 5
494YNNCyclothiazide
GRIA3: glutamate receptor, ionotrophic, AMPA 30.26667Diazoxide
0.73123GRIA2: glutamate receptor, ionotropic, AMPA 2
495NNNDiazoxide
SCN4B0.40000Zonisamide
0.044678KCNE1: potassium voltage-gated channel, Isk-related family, member 1
496NNNMetocurine iodide
CHRNA5: cholinergic receptor, nicotinic, alpha 50.67619Tubocurarine chloride
0.44323CHRNA2
497NNNVerapamil hydrochloride
SCN10A: sodium channel, voltage-gated, type X, alpha subunit0.97059Verapamil
0.12559CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
498NNNQuinidine gluconate
SCN11A: sodium channel, voltage-gated, type XI, alpha subunit0.20408Cocaine
0.46734SCN5A: sodium channel, voltage-gated, type V, alpha subunit
499NNNThioridazine hydrochloride
KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 20.64706Trifluoperazine hydrochloride
0.030674KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
500NNNHalazepam
GLRA1: glycine receptor, alpha 10.76000Diazepam
0.31459GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
501NNNCetiedil citrate
CHRNA20.33962Nicotine bitartrate
0.019239KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
502NNNQuinidine sulfate
KCNK17: potassium channel, subfamily K, member 170.20548Verapamil
0.34803KCNK16: potassium channel, subfamily K, member 16
503NNNRiluzole
GRIN1: glutamate receptor, ionotropic, N-methyl D-aspartate 10.23077Ketamine hydrochloride
0.15710GRIK1: glutamate receptor, ionotropic, kainate 1
504NNNIbutilide fumarate
CACNB3: calcium channel, voltage-dependent, beta 3 subunit0.29167Verapamil
0.49490CACNB1: calcium channel, voltage-dependent, beta 1 subunit
505NNNProcaine hydrochloride
SCN11A: sodium channel, voltage-gated, type XI, alpha subunit0.33333Cocaine
0.47691SCN10A: sodium channel, voltage-gated, type X, alpha subunit
506NNNVerapamil
P2RX5: purinergic receptor P2X, ligand-gated ion channel, 50.17500Caffeine
0.045889KCNE1L: KCNE1-like
507NNNChlorothiazide
GRIA2: glutamate receptor, ionotropic, AMPA 20.51852Cyclothiazide
0.010212KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 1
508NNNTolazamide
KCNJ8: potassium inwardly-rectifying channel, subfamily J, member 80.25000Diazoxide
0.66902KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11
509NNNQuinine hydrochloride hydrate
KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 20.29546Diltiazem hydrochloride
0.66887KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
510NNYPentobarbital calcium
GABRG2: gamma-aminobutyric acid (GABA) A receptor, gamma 20.40000Pentobarbital
0.43368GABRA6: gamma-aminobutyric acid (GABA) A receptor, alpha 6
511NNNFelodipine
CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit0.75862Nitrendipine
0.10257CACNA1F: calcium channel, voltage-dependent, L type, alpha 1F subunit
512NNNFelbamate
GRIN3B: glutamate receptor, ionotropic, N-methyl-D-aspartate 3B0.19444Haloperidol
0.44349GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A
513NNNFlecainide acetate
KCNC4: potassium voltage-gated channel, Shaw-related subfamily, member 40.20370Verapamil
0.64803KCNC1: potassium voltage-gated channel, Shaw-related subfamily, member 1
514YNYPrilocaine
SCN3A: sodium channel, voltage-gated, type III, alpha subunit0.94118Prilocaine hydrochloride
0.60341SCN5A: sodium channel, voltage-gated, type V, alpha subunit
515NYNVerapamil hydrochloride
SCN5A: sodium channel, voltage-gated, type V, alpha subunit0.97059Verapamil
0.11951CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
516NNNDisopyramide
CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit0.34884Verapamil
0.13386SCN5A: sodium channel, voltage-gated, type V, alpha subunit
517NNNMefloquine hydrochloride
GRIA1: glutamate receptor, ionotropic, AMPA 10.31250Riluzole
0.011082KCNQ1: potassium voltage-gated channel, KQT-like subfamily, member 1
518NNNGlyburide
KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 40.40816Ketoconazole
0.017942ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 8
519NNNLoratadine
KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 20.32558Diltiazem hydrochloride
0.55968KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5
520NNNDiazepam
GRIA1: glutamate receptor, ionotropic, AMPA 10.30769Diazoxide
0.018959GLRA1: glycine receptor, alpha 1
521NNNGallopamil hydrochloride
CACNG1: calcium channel, voltage-dependent, gamma subunit 10.86486Verapamil
0.012500CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
522NNYTubocurarine chloride
CHRNE: cholinergic receptor, nicotinic, epsilon0.16364Nicotine
0.31221CHRNA3: cholinergic receptor, nicotinic, alpha 3
523NNNAmlodipine besylate
KCNA4: potassium voltage-gated channel, shaker-related subfamily, member 40.57447Nicardipine hydrochloride
0.020088CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
524YYYRepaglinide
ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 80.43478Glyburide
0.013742KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
525NNNIbutilide fumarate
KCNK16: potassium channel, subfamily K, member 160.29167Verapamil
0.24996KCNK6: potassium channel, subfamily K, member 6
526NNNBupivacaine hydrochloride
KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 20.34146Flecainide acetate
0.55968KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5
527NNNZonisamide
KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 10.40000Diazoxide
0.016547SCN1B: sodium channel, voltage-gated, type I, beta
528NNNVerapamil
P2RX3: purinergic receptor P2X, ligand-gated ion channel, 30.17500Caffeine
0.030341KCNE2: potassium voltage-gated channel, Isk-related family, member 2
529NNYTolazamide
ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 80.56000Tolbutamide
0.013742KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
530NNNMepivacaine hydrochloride
KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 50.75000Bupivacaine hydrochloride
0.026637KCNK5: potassium channel, subfamily K, member 5
531NNNExemestane
CHRNE: cholinergic receptor, nicotinic, epsilon0.18750Pentobarbital
0.31850CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)
532NNNEncainide hydrochloride
KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 60.65625Thioridazine hydrochloride
0.016835SCN2A: sodium channel, voltage-gated, type II, alpha subunit
533NNNAmlodipine maleate
CACNG1: calcium channel, voltage-dependent, gamma subunit 10.48837Nisoldipine
0.018083CACNA1F: calcium channel, voltage-dependent, L type, alpha 1F subunit
534NNNVerapamil hydrochloride
KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 10.97059Verapamil
0.032967KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
535NNNHalazepam
GRIA1: glutamate receptor, ionotropic, AMPA 10.39286Riluzole
0.011445GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
536NNYMoricizine
SCN4A: sodium channel, voltage-gated, type IV, alpha subunit0.96774Moricizine hydrochloride
0.58238SCN5A: sodium channel, voltage-gated, type V, alpha subunit
537NNNAmlodipine besylate
CACNG1: calcium channel, voltage-dependent, gamma subunit 10.48837Nitrendipine
0.018083CACNA1F: calcium channel, voltage-dependent, L type, alpha 1F subunit
538NNNMetoclopramide
SCN10A: sodium channel, voltage-gated, type X, alpha subunit0.56000Chloroprocaine hydrochloride
0.013456CHRNA1: cholinergic receptor, nicotinic, alpha 1 (muscle)
539NNNVerapamil
P2RX6: purinergic receptor P2X, ligand-gated ion channel, 60.17500Caffeine
0.029220KCNE3: potassium voltage-gated channel, Isk-related family, member 3
540NNNHalofantrine hydrochloride
KCNH7: potassium voltage-gated channel, subfamily H (eag-related), member 70.36735Verapamil
0.52729KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2
541NYNZonisamide
SCN11A: sodium channel, voltage-gated, type XI, alpha subunit0.16129Cocaine
0.47691SCN10A: sodium channel, voltage-gated, type X, alpha subunit
542YYNSertraline
SLC6A3: solute carrier family 6 (neurotransmitter transporter, dopamine), member 30.53846Mazindol
0.48799SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
543NNNChloroprocaine hydrochloride
RYR2: ryanodine receptor 2 (cardiac)0.85000Procaine hydrochloride
0.0081086KCNK5: potassium channel, subfamily K, member 5
544NNNDiazoxide
CHRND: cholinergic receptor, nicotinic, delta0.25926Metoclopramide
0.029958KCNE3: potassium voltage-gated channel, Isk-related family, member 3
545NNNBenoxinate hydrochloride
SCN4A: sodium channel, voltage-gated, type IV, alpha subunit0.80000Proparacaine hydrochloride
0.51890SCN10A: sodium channel, voltage-gated, type X, alpha subunit
546NNNDequalinium chloride
KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 60.34783Thioridazine hydrochloride
0.032967KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1
547NNNVerapamil
GABRR20.30233Zaleplon
0.030883KCNE1L: KCNE1-like
548NNNFlecainide acetate
KCNC2: potassium voltage-gated channel, Shaw-related subfamily, member 20.22222Verapamil hydrochloride
0.63973KCNC1: potassium voltage-gated channel, Shaw-related subfamily, member 1
549NNNIsoflurane
KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 20.23529Flecainide acetate
0.79208KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
550NNNFluoxetine hydrochloride
KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 40.34091Ketoconazole
0.34860KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1
551NNYDisopyramide
SCN9A: sodium channel, voltage-gated, type IX, alpha subunit0.45714Propafenone hydrochloride
0.75410SCN3A: sodium channel, voltage-gated, type III, alpha subunit
552NNNChloroprocaine hydrochloride
RYR30.85000Procaine hydrochloride
0.0065468KCNK5: potassium channel, subfamily K, member 5
553NNNMetoclopramide
SCN5A: sodium channel, voltage-gated, type V, alpha subunit0.72727Procainamide hydrochloride
0.015351CHRNA4: cholinergic receptor, nicotinic, alpha 4
554NNNLevetiracetam
SCN3A: sodium channel, voltage-gated, type III, alpha subunit0.30769Dyclonine hydrochloride
0.83065SCN1A: sodium channel, voltage-gated, type I, alpha subunit
555NNNMefloquine hydrochloride
KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)0.47500Flecainide acetate
0.081115KCNQ1: potassium voltage-gated channel, KQT-like subfamily, member 1
556NNNVerapamil hydrochloride
KCNJ5: potassium inwardly-rectifying channel, subfamily J, member 50.97059Verapamil
0.70666KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
557NNNMethoxyflurane
GLRA30.071429Tropisetron hydrochloride
0.83309GLRA1: glycine receptor, alpha 1
558NNNAlprazolam
GLRA2: glycine receptor, alpha 20.68000Diazepam
0.32569GABRD: gamma-aminobutyric acid (GABA) A receptor, delta
559NNNVerapamil hydrochloride
KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 20.97059Verapamil
0.035140KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 10
560NNNPramoxine hydrochloride
KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 50.38461Flecainide acetate
0.026637KCNK5: potassium channel, subfamily K, member 5
561NYYNateglinide
ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 80.36585Glyburide
0.013742KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
562NNNFluoxetine
KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 40.34884Ketoconazole
0.34860KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1
563NNNVerapamil
P2RX1: purinergic receptor P2X, ligand-gated ion channel, 10.17500Caffeine
0.045455KCNE3: potassium voltage-gated channel, Isk-related family, member 3
564NNNExemestane
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.34483Hexobarbital
0.090264CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)
565NNNRiluzole
KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)0.38095Diazoxide
0.025836SCN4A: sodium channel, voltage-gated, type IV, alpha subunit
566NNNDofetilide
KCNK16: potassium channel, subfamily K, member 160.40909Verapamil
0.27152KCNK2: potassium channel, subfamily K, member 2
567NNNTerfenadine
KCNH6: potassium voltage-gated channel, subfamily H (eag-related), member 60.27114Verapamil
0.50037KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2
568NNYTopiramate
GRIK5: glutamate receptor, ionotropic, kainate 50.15152Kainic acid hydrate
0.37570GRIK1: glutamate receptor, ionotropic, kainate 1
569NNNVerapamil hydrochloride
KCNK5: potassium channel, subfamily K, member 50.97059Verapamil
0.032538KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 10
570NYNMagnesium sulfate
CACNB2: calcium channel, voltage-dependent, beta 2 subunit0.027027Nifedipine
0.015801CACNG1: calcium channel, voltage-dependent, gamma subunit 1
571NNNBupivacaine hydrochloride
KCND2: potassium voltage-gated channel, Shal-related subfamily, member 20.19355Diazoxide
0.74853KCND3: potassium voltage-gated channel, Shal-related subfamily, member 3
572NNNKetamine hydrochloride
GABRG30.37500Flurazepam
0.40101GABRA6: gamma-aminobutyric acid (GABA) A receptor, alpha 6
573NNNTolbutamide
ABCC9: ATP-binding cassette, sub-family C (CFTR/MRP), member 90.18605Verapamil
0.68192ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 8
574NNNTropisetron hydrochloride
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.39286Ketamine hydrochloride
0.32323GLRA3
575NNNProfenamine hydrochloride
GRIN3B: glutamate receptor, ionotropic, N-methyl-D-aspartate 3B0.37143Dizocilpine maleate
0.44349GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A
576NNNDesflurane
GABRA2: gamma-aminobutyric acid (GABA) A receptor, alpha 21Isoflurane
0.74880GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
577NNNCyproheptadine hydrochloride
CHRNA20.39317Tubocurarine chloride
0.018097KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
578NNNKetoconazole
KCNH7: potassium voltage-gated channel, subfamily H (eag-related), member 70.25455Verapamil
0.52729KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2
579NNNEnflurane
GLRA30.032258Tropisetron hydrochloride
0.83309GLRA1: glycine receptor, alpha 1
580NNNDiltiazem malate
KCNC2: potassium voltage-gated channel, Shaw-related subfamily, member 20.33962Verapamil
0.63973KCNC1: potassium voltage-gated channel, Shaw-related subfamily, member 1
581NNNZonisamide
CACNA1E: calcium channel, voltage-dependent, R type, alpha 1E subunit0.22222Phenytoin
0.12631CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
582NNNDofetilide
KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 10.41026Benzthiazide
0.022874KCNK2: potassium channel, subfamily K, member 2
583NNNIbutilide fumarate
KCNK2: potassium channel, subfamily K, member 20.41270Dofetilide
0.20401KCNK1: potassium channel, subfamily K, member 1
584NNNIsradipine
CACNG70.66667Nisoldipine
0.094539CACNG1: calcium channel, voltage-dependent, gamma subunit 1
585NYNFelodipine
CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit0.75862Nitrendipine
0.11063CACNA1F: calcium channel, voltage-dependent, L type, alpha 1F subunit
586NNNChloroprocaine hydrochloride
RYR1: ryanodine receptor 1 (skeletal)0.85000Procaine hydrochloride
0.0085784KCNK5: potassium channel, subfamily K, member 5
587NNNMethylphenidate
SCN10A: sodium channel, voltage-gated, type X, alpha subunit0.56000Cocaine
0.012733SLC6A3: solute carrier family 6 (neurotransmitter transporter, dopamine), member 3
588NNYTubocurarine chloride
CHRNB1: cholinergic receptor, nicotinic, beta 1 (muscle)0.16129Metoclopramide
0.34687CHRNA3: cholinergic receptor, nicotinic, alpha 3
589NNYTopiramate
GRIK4: glutamate receptor, ionotropic, kainate 40.15152Kainic acid hydrate
0.36616GRIK1: glutamate receptor, ionotropic, kainate 1
590NNNDiazoxide
CHRNB1: cholinergic receptor, nicotinic, beta 1 (muscle)0.25926Metoclopramide
0.035142KCNK4: potassium channel, subfamily K, member 4
591NNNProcainamide hydrochloride
CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)0.72727Metoclopramide
0.010863SCN3A: sodium channel, voltage-gated, type III, alpha subunit
592NNNNicotine bitartrate
CHRNE: cholinergic receptor, nicotinic, epsilon0.35294Nicotine
0.31221CHRNA3: cholinergic receptor, nicotinic, alpha 3
593NNNCarbamazepine
SCN11A: sodium channel, voltage-gated, type XI, alpha subunit0.17647Cocaine
0.47691SCN10A: sodium channel, voltage-gated, type X, alpha subunit
594NNYTopiramate
SCN3A: sodium channel, voltage-gated, type III, alpha subunit0.20000Mexiletine hydrochloride
0.83065SCN1A: sodium channel, voltage-gated, type I, alpha subunit
595NNNEthchlorvynol
GLRA1: glycine receptor, alpha 10.21429Methoxyflurane
0.31459GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
596NNNMagnesium sulfate
KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 110.10345Glyclopyramide
0.025831CACNG1: calcium channel, voltage-dependent, gamma subunit 1
597NNNTocainide
SCN10A: sodium channel, voltage-gated, type X, alpha subunit0.63158Lidocaine
0.60410SCN5A: sodium channel, voltage-gated, type V, alpha subunit
598NNYDisopyramide
SCN8A: sodium channel, voltage gated, type VIII, alpha subunit0.45714Propafenone hydrochloride
0.72659SCN3A: sodium channel, voltage-gated, type III, alpha subunit
599NNNRopivacaine hydrochloride
KCND3: potassium voltage-gated channel, Shal-related subfamily, member 30.87500Bupivacaine hydrochloride
0.027135KCNK5: potassium channel, subfamily K, member 5
600NNNLetrozole
KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 20.34884Ketoconazole
0.017956CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)
601NNNGallopamil hydrochloride
KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 30.86486Verapamil
0.0096347CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
602NNNCisapride
KCNH7: potassium voltage-gated channel, subfamily H (eag-related), member 70.35417Verapamil
0.52729KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2
603NNNTubocurarine chloride
KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 40.30378Ketoconazole
0.34860KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1
604NNNGranisetron
KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 10.48387Nateglinide
0.017658HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A
605NNNAminoglutethimide
CHRNA20.32000Pentobarbital
0.44784CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)
606NNNDiazoxide
SCN3B: sodium channel, voltage-gated, type III, beta0.40000Zonisamide
0.046014KCNE2: potassium voltage-gated channel, Isk-related family, member 2
607NNNIsradipine
TRPV6: transient receptor potential cation channel, subfamily V, member 60.66667Nisoldipine
0.019119CACNG1: calcium channel, voltage-dependent, gamma subunit 1
608NNNFelbamate
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.40000Etomidate
0.31643GLRA2: glycine receptor, alpha 2
609NNNGallopamil hydrochloride
KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)0.86486Verapamil
0.023214CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
610NNNDequalinium chloride
KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 20.40000Halofantrine hydrochloride
0.017196KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1
611NNNProfenamine hydrochloride
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.56250Flurazepam
0.011071GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A
612NNNFurosemide
GABRG2: gamma-aminobutyric acid (GABA) A receptor, gamma 20.32258Diazepam
0.43368GABRA6: gamma-aminobutyric acid (GABA) A receptor, alpha 6
613NNNGlipizide
KCNJ8: potassium inwardly-rectifying channel, subfamily J, member 80.25000Diazoxide
0.66902KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11
614NNYTocainide
SCN3A: sodium channel, voltage-gated, type III, alpha subunit0.93333Tocainide hydrochloride
0.60341SCN5A: sodium channel, voltage-gated, type V, alpha subunit
615NNNCisapride
KCNH7: potassium voltage-gated channel, subfamily H (eag-related), member 70.34694Verapamil
0.52729KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2
616NNNMidazolam
GLRB0.59259Diazepam
0.29609GABRB1
617NNNPrilocaine
KCNK5: potassium channel, subfamily K, member 50.94118Prilocaine hydrochloride
0.010777SCN5A: sodium channel, voltage-gated, type V, alpha subunit
618NNNQuinine hydrochloride hydrate
KCNB1: potassium voltage-gated channel, Shab-related subfamily, member 10.24242Diazoxide
0.58646KCNB2: potassium voltage-gated channel, Shab-related subfamily, member 2
619YNYCocaine
SCN1A: sodium channel, voltage-gated, type I, alpha subunit0.33333Procaine hydrochloride
0.60301SCN5A: sodium channel, voltage-gated, type V, alpha subunit
620NNNDiazepam
KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)0.38889Diltiazem hydrochloride
0.019626GABRD: gamma-aminobutyric acid (GABA) A receptor, delta
621NNNButabarbital
CHRNE: cholinergic receptor, nicotinic, epsilon0.82353Pentobarbital
0.072378GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
622NNNIsradipine
TRPA1: transient receptor potential cation channel, subfamily A, member 10.66667Nisoldipine
0.015142CACNG1: calcium channel, voltage-dependent, gamma subunit 1
623NYNNimodipine
CACNB4: calcium channel, voltage-dependent, beta 4 subunit0.75000Nitrendipine
0.54913CACNB2: calcium channel, voltage-dependent, beta 2 subunit
624NNNFluoxetine
KCNJ5: potassium inwardly-rectifying channel, subfamily J, member 50.34146Verapamil
0.70666KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
625YNYBenzocaine
SCN2A: sodium channel, voltage-gated, type II, alpha subunit0.57895Procaine hydrochloride
0.86296SCN3A: sodium channel, voltage-gated, type III, alpha subunit
626NNNDiazoxide
SLC6A1: solute carrier family 6 (neurotransmitter transporter, GABA), member 10.16129Cocaine
0.026833KCND2: potassium voltage-gated channel, Shal-related subfamily, member 2
627NNNPromethazine hydrochloride
KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 60.56667Thioridazine hydrochloride
0.024221KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
628NNNProline
SLC6A3: solute carrier family 6 (neurotransmitter transporter, dopamine), member 30.19048Methylphenidate
0.40340SLC6A7: solute carrier family 6 (neurotransmitter transporter, L-proline), member 7
629NYNButabarbital
GABRA5: gamma-aminobutyric acid (GABA) A receptor, alpha 50.82353Pentobarbital
0.69495GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
630NNNGranisetron hydrochloride
GLRA1: glycine receptor, alpha 10.53333Tropisetron hydrochloride
0.098396HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A
631NNNBenoxinate hydrochloride
SCN3A: sodium channel, voltage-gated, type III, alpha subunit0.80000Proparacaine hydrochloride
0.54531SCN10A: sodium channel, voltage-gated, type X, alpha subunit
632NNNRopivacaine hydrochloride
KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 60.87500Bupivacaine hydrochloride
0.021715KCNK5: potassium channel, subfamily K, member 5
633NNNBenzocaine
CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit0.31034Nitrendipine
0.13951SCN3A: sodium channel, voltage-gated, type III, alpha subunit
634NNNDesipramine hydrochloride
KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 60.51613Thioridazine hydrochloride
0.024221KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
635NNNBenoxinate hydrochloride
KCNK5: potassium channel, subfamily K, member 50.70833Procaine hydrochloride
0.011241SCN10A: sodium channel, voltage-gated, type X, alpha subunit
636NNNButabarbital
CHRNA20.82353Pentobarbital
0.077681GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
637NNNVerapamil
P2RX4: purinergic receptor P2X, ligand-gated ion channel, 40.17500Caffeine
0.033352KCNE2: potassium voltage-gated channel, Isk-related family, member 2
638NNNPhencyclidine hydrochloride
CHRNE: cholinergic receptor, nicotinic, epsilon0.40909Nicotine
0.31221CHRNA3: cholinergic receptor, nicotinic, alpha 3
639NNNMagnesium sulfate
CACNA2D2: calcium channel, voltage-dependent, alpha 2/delta subunit 20.027027Nifedipine
0.52208CACNA2D1: calcium channel, voltage-dependent, alpha 2/delta subunit 1
640NNNHalofantrine hydrochloride
KCNH6: potassium voltage-gated channel, subfamily H (eag-related), member 60.36735Verapamil
0.50037KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2
641NNNDiazoxide
SCN1B: sodium channel, voltage-gated, type I, beta0.40000Zonisamide
0.045507KCNE2: potassium voltage-gated channel, Isk-related family, member 2
642NNNBenoxinate hydrochloride
SCN1A: sodium channel, voltage-gated, type I, alpha subunit0.80000Proparacaine hydrochloride
0.53503SCN10A: sodium channel, voltage-gated, type X, alpha subunit
643NNNMethoxyflurane
KCNK13: potassium channel, subfamily K, member 130.66667Halothane
0.027455KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
644NNNMethoxyflurane
KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 10.66667Halothane
0.031390KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
645NNNQuinine hydrochloride hydrate
KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 70.60000Quinidine gluconate
0.56382KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
646NNNFluphenazine maleate
KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 10.36364Fluoxetine
0.55275KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
647NNNHalofantrine hydrochloride
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.38636Flurazepam
0.012494KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2
648NNNLetrozole
CHRNE: cholinergic receptor, nicotinic, epsilon0.13333Nicotine
0.31850CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)
649NNNPhentermine
SCN5A: sodium channel, voltage-gated, type V, alpha subunit0.38889Mexiletine hydrochloride
0.010278SLC6A3: solute carrier family 6 (neurotransmitter transporter, dopamine), member 3
650NNNDyclonine hydrochloride
KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 50.45161Bupivacaine hydrochloride
0.026637KCNK5: potassium channel, subfamily K, member 5
651NNNDiazoxide
P2RX2: purinergic receptor P2X, ligand-gated ion channel, 20.21739Caffeine
0.042682KCNK4: potassium channel, subfamily K, member 4
652NNNVerapamil hydrochloride
KCNJ9: potassium inwardly-rectifying channel, subfamily J, member 90.97059Verapamil
0.68294KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
653NNYMoricizine
SCN3A: sodium channel, voltage-gated, type III, alpha subunit0.96774Moricizine hydrochloride
0.60341SCN5A: sodium channel, voltage-gated, type V, alpha subunit
654NNNVerapamil hydrochloride
CACNG1: calcium channel, voltage-dependent, gamma subunit 10.97059Verapamil
0.024826KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
655NNNMetocurine iodide
CHRNA9: cholinergic receptor, nicotinic, alpha 90.67619Tubocurarine chloride
0.31065CHRNA2
656NNNNateglinide
SCN5A: sodium channel, voltage-gated, type V, alpha subunit0.44828Mepivacaine hydrochloride
0.0099976KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
657NNNGallopamil hydrochloride
KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 10.86486Verapamil
0.0077683CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
658NNNKainic acid hydrate
GRIA1: glutamate receptor, ionotropic, AMPA 10.043478Methoxyflurane
0.35409GRIK2: glutamate receptor, ionotropic, kainate 2
659NNNDextromethorphan
CHRNA3: cholinergic receptor, nicotinic, alpha 30.53571Codeine
0.52424CHRNA2
660NNNMethohexital
CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)0.59091Pentobarbital
0.090264GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
661NNNVerapamil hydrochloride
SCN3A: sodium channel, voltage-gated, type III, alpha subunit0.97059Verapamil
0.13105CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
662YNNTubocurarine chloride
GABRE0.23975Midazolam
0.33697GABRA6: gamma-aminobutyric acid (GABA) A receptor, alpha 6
663NNNRepaglinide
KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 110.37650Glipizide
0.39373KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
664NNNRiluzole
CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit0.26923Amiloride hydrochloride
0.13120SCN5A: sodium channel, voltage-gated, type V, alpha subunit
665NNNMetocurine iodide
CHRNA1: cholinergic receptor, nicotinic, alpha 1 (muscle)0.67619Tubocurarine chloride
0.42204CHRNA2
666NNNDiltiazem hydrochloride
KCNC4: potassium voltage-gated channel, Shaw-related subfamily, member 40.36956Verapamil
0.64803KCNC1: potassium voltage-gated channel, Shaw-related subfamily, member 1
667NNNBepridil hydrochloride
SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 20.45714Trimipramine
0.014048KCNQ4: potassium voltage-gated channel, KQT-like subfamily, member 4
668NNNGliclazide
KCNJ8: potassium inwardly-rectifying channel, subfamily J, member 80.24138Diazoxide
0.66902KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11
669NNNDisopyramide
CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit0.34884Verapamil
0.13951SCN3A: sodium channel, voltage-gated, type III, alpha subunit
670NNYMinoxidil
KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 110.28571Tolazamide
0.39373KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
671NNNKetoconazole
KCNH6: potassium voltage-gated channel, subfamily H (eag-related), member 60.25455Verapamil
0.50037KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2
672NNNFlurazepam
GLRA2: glycine receptor, alpha 20.62069Diazepam
0.32569GABRD: gamma-aminobutyric acid (GABA) A receptor, delta
673NNNEnoxacin hydrate
GABRG2: gamma-aminobutyric acid (GABA) A receptor, gamma 20.22500Flurazepam
0.43368GABRA6: gamma-aminobutyric acid (GABA) A receptor, alpha 6
674NNNGallopamil hydrochloride
CACNA2D1: calcium channel, voltage-dependent, alpha 2/delta subunit 10.86486Verapamil
0.0064963CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
675NNNThiamylal
CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)0.65000Pentobarbital
0.090264GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
676NNNQuinine sulfate
KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 20.20779Diltiazem malate
0.66887KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
677NNNAnastrozole
CHRNA20.23529Metoclopramide
0.44784CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)
678NNNMoricizine
SCN10A: sodium channel, voltage-gated, type X, alpha subunit0.41176Carbamazepine
0.60410SCN5A: sodium channel, voltage-gated, type V, alpha subunit
679NNNPenicillin G procaine
GABRG2: gamma-aminobutyric acid (GABA) A receptor, gamma 20.38776Flurazepam
0.43368GABRA6: gamma-aminobutyric acid (GABA) A receptor, alpha 6
680NNNPhenacemide
SCN4A: sodium channel, voltage-gated, type IV, alpha subunit0.40000Tocainide hydrochloride
0.63042SCN1A: sodium channel, voltage-gated, type I, alpha subunit
681NNNFlecainide acetate
KCNC3: potassium voltage-gated channel, Shaw-related subfamily, member 30.20370Verapamil
0.57702KCNC1: potassium voltage-gated channel, Shaw-related subfamily, member 1
682NNNAmlexanox
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.38710Furosemide
0.010906ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 8
683NNNBenzocaine
GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A0.45000Felbamate
0.022827SCN4B
684NNNKetoconazole
KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 70.31884Quinidine sulfate
0.54502KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 10
685NNNPhenacemide
KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 10.38461Nateglinide
0.011295SCN1A: sodium channel, voltage-gated, type I, alpha subunit
686NNNFelodipine
KCNA4: potassium voltage-gated channel, shaker-related subfamily, member 40.56410Nicardipine hydrochloride
0.020088CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
687NYNPrimidone
GABRA2: gamma-aminobutyric acid (GABA) A receptor, alpha 20.43478Ketamine hydrochloride
0.74880GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
688NNNBiperiden
CHRNA3: cholinergic receptor, nicotinic, alpha 30.50000Phencyclidine hydrochloride
0.52424CHRNA2
689NNNMethylphenidate
SLC6A7: solute carrier family 6 (neurotransmitter transporter, L-proline), member 70.19048Proline
0.41013SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
690NNNQuinine sulfate
KCNK5: potassium channel, subfamily K, member 51Quinidine sulfate
0.028410KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
691NNNMefloquine hydrochloride
KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 10.31707Bendroflumethiazide
0.022575KCNQ1: potassium voltage-gated channel, KQT-like subfamily, member 1
692NNNMetocurine iodide
CHRNA100.67619Tubocurarine chloride
0.30303CHRNA2
693NNNIsradipine
CACNG2: calcium channel, voltage-dependent, gamma subunit 20.66667Nisoldipine
0.093335CACNG1: calcium channel, voltage-dependent, gamma subunit 1
694NNNKetoconazole
KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 30.32000Diltiazem hydrochloride
0.53242KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 10
695NNNDiazoxide
SCN4A: sodium channel, voltage-gated, type IV, alpha subunit0.40000Zonisamide
0.030864KCNV1: potassium channel, subfamily V, member 1
696NNNQuinidine gluconate
KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 100.25862Ketoconazole
0.54502KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
697NNNMitiglinide calcium hydrate
KCNJ8: potassium inwardly-rectifying channel, subfamily J, member 80.15493Verapamil
0.66902KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11
698NYNMagnesium sulfate
CACNB1: calcium channel, voltage-dependent, beta 1 subunit0.042857Ibutilide fumarate
0.016265CACNG1: calcium channel, voltage-dependent, gamma subunit 1
699NNNGlyclopyramide
KCNJ8: potassium inwardly-rectifying channel, subfamily J, member 80.32000Diazoxide
0.66902KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11
700NNNTrichlormethiazide
GRIA2: glutamate receptor, ionotropic, AMPA 20.62963Cyclothiazide
0.010212KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 1
701NNNLoratadine
KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 30.35000Quinine hydrochloride hydrate
0.53491KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5
702NNNPentobarbital
HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A0.16129Metoclopramide
0.26265CHRNA10
703NNNCodeine sulfate
KCNB2: potassium voltage-gated channel, Shab-related subfamily, member 20.39744Quinine sulfate
0.015233CHRNA3: cholinergic receptor, nicotinic, alpha 3
704NNNVerapamil
GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A0.36585Profenamine hydrochloride
0.023718KCNE2: potassium voltage-gated channel, Isk-related family, member 2
705NNNParoxetine
SLC6A1: solute carrier family 6 (neurotransmitter transporter, GABA), member 10.27778Cocaine
0.41406SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
706NNNKetamine hydrochloride
GABRE0.37500Flurazepam
0.33697GABRA6: gamma-aminobutyric acid (GABA) A receptor, alpha 6
707NNNDisopyramide
SCN11A: sodium channel, voltage-gated, type XI, alpha subunit0.20513Cocaine
0.47691SCN10A: sodium channel, voltage-gated, type X, alpha subunit
708NNNMefloquine hydrochloride
GLRA1: glycine receptor, alpha 10.32432Tropisetron hydrochloride
0.015107KCNQ1: potassium voltage-gated channel, KQT-like subfamily, member 1
709NNNFelbamate
GRIA1: glutamate receptor, ionotropic, AMPA 10.18518Riluzole
0.092521GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A
710NYNButabarbital
GABRA3: gamma-aminobutyric acid (GABA) A receptor, alpha 30.82353Pentobarbital
0.66731GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
711YNYDibucaine
SCN1A: sodium channel, voltage-gated, type I, alpha subunit0.48276Procainamide hydrochloride
0.60301SCN5A: sodium channel, voltage-gated, type V, alpha subunit
712NNNGabapentin
GRIN3B: glutamate receptor, ionotropic, N-methyl-D-aspartate 3B0.20833Ketamine hydrochloride
0.44349GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A
713NNNAzimilide dihydrochloride
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.38636Flurazepam
0.015344KCNQ1: potassium voltage-gated channel, KQT-like subfamily, member 1
714NNNVerapamil hydrochloride
KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 10.97059Verapamil
0.39592KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
715NNNHydroflumethiazide
GRIA2: glutamate receptor, ionotropic, AMPA 20.51724Cyclothiazide
0.010212KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 1
716NNNEthchlorvynol
GRIA1: glutamate receptor, ionotropic, AMPA 10.21429Methoxyflurane
0.011445GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
717NNYPentobarbital calcium
GABRG30.40000Pentobarbital
0.40101GABRA6: gamma-aminobutyric acid (GABA) A receptor, alpha 6
718NNNPhencyclidine hydrochloride
HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A0.40909Nicotine
0.26265CHRNA10
719NNNFluoxetine hydrochloride
KCNJ5: potassium inwardly-rectifying channel, subfamily J, member 50.33333Verapamil
0.70666KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
720NNNQuinine sulfate
KCNB1: potassium voltage-gated channel, Shab-related subfamily, member 10.20548Verapamil
0.58646KCNB2: potassium voltage-gated channel, Shab-related subfamily, member 2
721NYNFelodipine
CACNA2D1: calcium channel, voltage-dependent, alpha 2/delta subunit 10.75862Nitrendipine
0.0064963CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
722NNNVerapamil
HTR3D: 5-hydroxytryptamine (serotonin) receptor 3 family member D0.23404Ondansetron hydrochloride hydrate
0.042488KCNMB1: potassium large conductance calcium-activated channel, subfamily M, beta member 1
723YNNParoxetine
SLC6A3: solute carrier family 6 (neurotransmitter transporter, dopamine), member 30.46667Mazindol
0.48799SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
724YNNPhenytoin
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.56000Oxazepam
0.025549SCN4B
725NNNQuinidine sulfate
KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)0.20779Diltiazem malate
0.59825KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
726NYNAmlodipine besylate
CACNB2: calcium channel, voltage-dependent, beta 2 subunit0.48837Nitrendipine
0.017211CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
727YNYCarbamazepine
SCN9A: sodium channel, voltage-gated, type IX, alpha subunit0.40000Moricizine hydrochloride
0.75410SCN3A: sodium channel, voltage-gated, type III, alpha subunit
728NNNCisapride
KCNH6: potassium voltage-gated channel, subfamily H (eag-related), member 60.35417Verapamil
0.50037KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2
729NNNProfenamine hydrochloride
SCN5A: sodium channel, voltage-gated, type V, alpha subunit0.53125Propafenone hydrochloride
0.0097377GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A
730NNNMirtazapine
SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 20.51852Maprotiline
0.018814HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A
731NNYTubocurarine chloride
CHRND: cholinergic receptor, nicotinic, delta0.16129Metoclopramide
0.33926CHRNA3: cholinergic receptor, nicotinic, alpha 3
732NNNAmiodarone hydrochloride
KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 100.40425Verapamil hydrochloride
0.54502KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
733NNNDiazoxide
SLC6A14: solute carrier family 6 (amino acid transporter), member 140Proline
0.033290KCNK17: potassium channel, subfamily K, member 17
734NNNDiltiazem malate
KCNC4: potassium voltage-gated channel, Shaw-related subfamily, member 40.33962Verapamil
0.64803KCNC1: potassium voltage-gated channel, Shaw-related subfamily, member 1
735YNNCocaine
SCN8A: sodium channel, voltage gated, type VIII, alpha subunit0.33333Procaine hydrochloride
0.58865SCN5A: sodium channel, voltage-gated, type V, alpha subunit
736YYYDesipramine hydrochloride
SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 20.72000Trimipramine
0.017087KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
737NNNQuinine hydrochloride hydrate
KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)0.29546Diltiazem hydrochloride
0.66583KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
738NNNFluphenazine maleate
KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 60.48837Thioridazine hydrochloride
0.024221KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
739NNNMaprotiline
KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 60.53333Thioridazine
0.020826SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
740NNNEthosuximide
CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)0.44444Pentobarbital
0.0094499CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit
741NNNCisapride
KCNH6: potassium voltage-gated channel, subfamily H (eag-related), member 60.34694Verapamil
0.50037KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2
742NNNProparacaine hydrochloride
SCN11A: sodium channel, voltage-gated, type XI, alpha subunit0.25714Cocaine
0.47691SCN10A: sodium channel, voltage-gated, type X, alpha subunit
743NNYCocaine
SCN9A: sodium channel, voltage-gated, type IX, alpha subunit0.33333Procaine hydrochloride
0.59648SCN5A: sodium channel, voltage-gated, type V, alpha subunit
744NNNMetocurine iodide
CHRNA7: cholinergic receptor, nicotinic, alpha 70.67619Tubocurarine chloride
0.34519CHRNA2
745NNNDopamine hydrochloride
KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 10.35294Chlorzoxazone
0.015696HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A
746NNNPropafenone hydrochloride
KCNA4: potassium voltage-gated channel, shaker-related subfamily, member 40.34091Verapamil
0.48532KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5
747NYNNimodipine
CACNB3: calcium channel, voltage-dependent, beta 3 subunit0.75000Nitrendipine
0.48563CACNB2: calcium channel, voltage-dependent, beta 2 subunit
748NNNMefloquine hydrochloride
KCNE1: potassium voltage-gated channel, Isk-related family, member 10.24390Indapamide
0.026945KCNQ1: potassium voltage-gated channel, KQT-like subfamily, member 1
749NNNThioridazine hydrochloride
KCNJ5: potassium inwardly-rectifying channel, subfamily J, member 50.34091Verapamil
0.70666KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
750NNNPrimidone
SCN5A: sodium channel, voltage-gated, type V, alpha subunit0.72222Ethotoin
0.0092349GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
751NNNDiazoxide
GRIN1: glutamate receptor, ionotropic, N-methyl D-aspartate 10.29167Ketamine hydrochloride
0.14656GRIA1: glutamate receptor, ionotropic, AMPA 1
752NNNMaprotiline
SCN5A: sodium channel, voltage-gated, type V, alpha subunit0.45714Moricizine
0.0094747SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
753NNNNicotine bitartrate
KCNB2: potassium voltage-gated channel, Shab-related subfamily, member 20.24490Quinine hydrochloride hydrate
0.18777KCND3: potassium voltage-gated channel, Shal-related subfamily, member 3
754NNNThioridazine
KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 20.61765Trifluoperazine hydrochloride
0.030674KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
755NNNFluoxetine
KCNJ9: potassium inwardly-rectifying channel, subfamily J, member 90.34146Verapamil
0.68294KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
756NNNHalothane
GABRA2: gamma-aminobutyric acid (GABA) A receptor, alpha 20.54546Isoflurane
0.74880GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
757NYNButabarbital
CHRNA4: cholinergic receptor, nicotinic, alpha 40.82353Pentobarbital
0.076957GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
758NNNSumatriptan
KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 10.36000Diazoxide
0.015696HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A
759NNNIsradipine
CACNG4: calcium channel, voltage-dependent, gamma subunit 40.66667Nisoldipine
0.077119CACNG1: calcium channel, voltage-dependent, gamma subunit 1
760NNNVerapamil hydrochloride
KCNC3: potassium voltage-gated channel, Shaw-related subfamily, member 30.97059Verapamil
0.47605KCNC2: potassium voltage-gated channel, Shaw-related subfamily, member 2
761NNNDofetilide
CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit0.41270Ibutilide fumarate
0.011007KCNH5: potassium voltage-gated channel, subfamily H (eag-related), member 5
762NYNGalantamine hydrobromide
CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)0.25926Nicotine
0.44784CHRNA2
763NNNTerfenadine
CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit0.60465Pimozide
0.0095753KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2
764NYNQuinidine sulfate
KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 20.32836Astemizole
0.22326KCNH1: potassium voltage-gated channel, subfamily H (eag-related), member 1
765NYNAmlodipine maleate
CACNB2: calcium channel, voltage-dependent, beta 2 subunit0.48837Nisoldipine
0.017211CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
766NNNMethoxyflurane
KCNK12: potassium channel, subfamily K, member 120.66667Halothane
0.029641KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
767NNNQuinine sulfate
KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 100.31884Ketoconazole
0.53242KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
768NNNMibefradil dihydrochloride
PKD1: polycystic kidney disease 1 (autosomal dominant)0.44898Verapamil
0.0049566CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
769NNNThioridazine
KCNJ5: potassium inwardly-rectifying channel, subfamily J, member 50.34884Verapamil
0.70666KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
770NNNDiazoxide
P2RX7: purinergic receptor P2X, ligand-gated ion channel, 70.21739Caffeine
0.027427KCNE2: potassium voltage-gated channel, Isk-related family, member 2
771NNNPhysostigmine sulfate
CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)0.17544Anastrozole
0.44784CHRNA2
772NNNNortriptyline hydrochloride
KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 60.48387Dizocilpine maleate
0.024221KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
773NNNMethylphenidate
SCN11A: sodium channel, voltage-gated, type XI, alpha subunit0.56000Cocaine
0.012283SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
774NNNMepivacaine hydrochloride
KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 60.75000Bupivacaine hydrochloride
0.021715KCNK5: potassium channel, subfamily K, member 5
775NNNMibefradil dihydrochloride
SCN10A: sodium channel, voltage-gated, type X, alpha subunit0.44898Verapamil
0.13474CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
776NNNDiazoxide
SLC6A7: solute carrier family 6 (neurotransmitter transporter, L-proline), member 70Proline
0.031499KCNK16: potassium channel, subfamily K, member 16
777NNNPropafenone hydrochloride
KCNC1: potassium voltage-gated channel, Shaw-related subfamily, member 10.34091Verapamil
0.21997KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5
778NNNAmlodipine besylate
CACNA2D4: calcium channel, voltage-dependent, alpha 2/delta subunit 40.48837Nitrendipine
0.0092209CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
779NNNDiazoxide
GLRA30.24138Tropisetron hydrochloride
0.029733KCNE1L: KCNE1-like
780NNNPhencyclidine hydrochloride
KCND3: potassium voltage-gated channel, Shal-related subfamily, member 30.31250Bupivacaine hydrochloride
0.18777KCNB2: potassium voltage-gated channel, Shab-related subfamily, member 2
781NNNDopamine hydrochloride
GLRA2: glycine receptor, alpha 20.26087Felbamate
0.10113HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A
782NNNDextromethorphan
CHRNA6: cholinergic receptor, nicotinic, alpha 60.53571Codeine
0.49191CHRNA2
783NNNMazindol
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.53846Diazepam
0.016836SLC6A3: solute carrier family 6 (neurotransmitter transporter, dopamine), member 3
784NNNBupivacaine hydrochloride
SCN11A: sodium channel, voltage-gated, type XI, alpha subunit0.28571Cocaine
0.47691SCN10A: sodium channel, voltage-gated, type X, alpha subunit
785NNYThiamylal
GABRA2: gamma-aminobutyric acid (GABA) A receptor, alpha 20.65000Pentobarbital
0.74880GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
786NNNNicotine bitartrate
KCND1: potassium voltage-gated channel, Shal-related subfamily, member 10.11628Diazoxide
0.62617KCND3: potassium voltage-gated channel, Shal-related subfamily, member 3
787YNYCarbamazepine
SCN8A: sodium channel, voltage gated, type VIII, alpha subunit0.40000Moricizine hydrochloride
0.72659SCN3A: sodium channel, voltage-gated, type III, alpha subunit
788NNNLamotrigine
KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 10.35000Chlorzoxazone
0.011633SCN3A: sodium channel, voltage-gated, type III, alpha subunit
789NNNTetracaine hydrochloride
SCN11A: sodium channel, voltage-gated, type XI, alpha subunit0.31250Cocaine
0.47691SCN10A: sodium channel, voltage-gated, type X, alpha subunit
790NNNDiazoxide
SCN11A: sodium channel, voltage-gated, type XI, alpha subunit0.16129Cocaine
0.027170KCNF1: potassium voltage-gated channel, subfamily F, member 1
791NNNPenfluridol
KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 20.48333Trifluoperazine hydrochloride
0.011237CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
792NNNDesflurane
GLRA30.032258Tropisetron hydrochloride
0.83309GLRA1: glycine receptor, alpha 1
793NNNBiperiden
CHRNA6: cholinergic receptor, nicotinic, alpha 60.50000Phencyclidine hydrochloride
0.49191CHRNA2
794NNNParoxetine
KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 20.43590Cisapride
0.013109SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
795NNNButabarbital
CHRNA100.82353Pentobarbital
0.086146GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
796NNNAstemizole
KCNH7: potassium voltage-gated channel, subfamily H (eag-related), member 70.28846Verapamil
0.52729KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2
797NNNMethylphenidate
SLC6A14: solute carrier family 6 (amino acid transporter), member 140.19048Proline
0.38254SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
798NNNZaleplon
SCN5A: sodium channel, voltage-gated, type V, alpha subunit0.37143Disopyramide
0.013396GABRE
799NNNVerapamil hydrochloride
CACNA2D1: calcium channel, voltage-dependent, alpha 2/delta subunit 10.97059Verapamil
0.014097KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 10
800NNNIsradipine
ITPR1: inositol 1,4,5-trisphosphate receptor, type 10.66667Nisoldipine
0.0095944CACNG1: calcium channel, voltage-dependent, gamma subunit 1
801NNNButabarbital
CHRNA9: cholinergic receptor, nicotinic, alpha 90.82353Pentobarbital
0.086245GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
802NNNPhysostigmine sulfate
KCNB2: potassium voltage-gated channel, Shab-related subfamily, member 20.36986Quinine sulfate
0.015233CHRNA3: cholinergic receptor, nicotinic, alpha 3
803NNNBupivacaine hydrochloride
SCN7A: sodium channel, voltage-gated, type VII, alpha0.29730Disopyramide
0.48453SCN9A: sodium channel, voltage-gated, type IX, alpha subunit
804NNNLamotrigine
SCN7A: sodium channel, voltage-gated, type VII, alpha0.40909Riluzole
0.48453SCN9A: sodium channel, voltage-gated, type IX, alpha subunit
805NNNPhencyclidine hydrochloride
KCNB1: potassium voltage-gated channel, Shab-related subfamily, member 10.17857Diazoxide
0.58646KCNB2: potassium voltage-gated channel, Shab-related subfamily, member 2
806NNNPropafenone hydrochloride
KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)0.34091Verapamil
0.55487KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5
807NNNDiazoxide
GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A0.38095Riluzole
0.092521GRIA1: glutamate receptor, ionotropic, AMPA 1
808NNNDiazoxide
ACCN2: amiloride-sensitive cation channel 2, neuronal0.18518Amiloride hydrochloride
0.026659KCNE1L: KCNE1-like
809NNNDextromethorphan
CHRNA4: cholinergic receptor, nicotinic, alpha 40.53571Codeine
0.52847CHRNA2
810NNNCocaine
SCN7A: sodium channel, voltage-gated, type VII, alpha0.36000Benzocaine
0.38926SCN5A: sodium channel, voltage-gated, type V, alpha subunit
811NNNTolbutamide
SCN5A: sodium channel, voltage-gated, type V, alpha subunit0.50000Procainamide hydrochloride
0.0099976KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
812NNNNicardipine hydrochloride
KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 30.40425Diltiazem hydrochloride
0.54817KCNA4: potassium voltage-gated channel, shaker-related subfamily, member 4
813NNNButabarbital
CHRNA6: cholinergic receptor, nicotinic, alpha 60.82353Pentobarbital
0.087197GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
814NNNDiltiazem hydrochloride
KCNC3: potassium voltage-gated channel, Shaw-related subfamily, member 30.36956Verapamil
0.57702KCNC1: potassium voltage-gated channel, Shaw-related subfamily, member 1
815NNNDiazoxide
ACCN1: amiloride-sensitive cation channel 1, neuronal0.18518Amiloride hydrochloride
0.027845KCNE4: potassium voltage-gated channel, Isk-related family, member 4
816NNYBepridil hydrochloride
KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 20.45454Terfenadine
0.017204KCNQ4: potassium voltage-gated channel, KQT-like subfamily, member 4
817NNNDibucaine
KCNK5: potassium channel, subfamily K, member 50.44828Lidocaine
0.011241SCN10A: sodium channel, voltage-gated, type X, alpha subunit
818NNNProcainamide hydrochloride
CHRNE: cholinergic receptor, nicotinic, epsilon0.72727Metoclopramide
0.011727SCN5A: sodium channel, voltage-gated, type V, alpha subunit
819NNNIsradipine
ITPR3: inositol 1,4,5-trisphosphate receptor, type 30.66667Nisoldipine
0.0092991CACNG1: calcium channel, voltage-dependent, gamma subunit 1
820NNNSertraline
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.48276Midazolam
0.014964SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
821NNNFlecainide acetate
SCN11A: sodium channel, voltage-gated, type XI, alpha subunit0.20000Cocaine
0.46734SCN5A: sodium channel, voltage-gated, type V, alpha subunit
822NNNMefloquine hydrochloride
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.30769Halazepam
0.015344KCNQ1: potassium voltage-gated channel, KQT-like subfamily, member 1
823NNNQuinine hydrochloride hydrate
KCNA4: potassium voltage-gated channel, shaker-related subfamily, member 40.60000Quinidine gluconate
0.54817KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
824NNNAmiodarone hydrochloride
SCN10A: sodium channel, voltage-gated, type X, alpha subunit0.58333Dibucaine
0.023243KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
825NNNFluphenazine hydrochloride
KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 60.56757Thioridazine hydrochloride
0.024221KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
826NNNCodeine
KCND3: potassium voltage-gated channel, Shal-related subfamily, member 30.35294Bupivacaine hydrochloride
0.020018CHRNA10
827NNNDiltiazem hydrochloride
KCNB2: potassium voltage-gated channel, Shab-related subfamily, member 20.36956Verapamil
0.22001KCNC1: potassium voltage-gated channel, Shaw-related subfamily, member 1
828NNNVerapamil hydrochloride
KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 10.97059Verapamil
0.034158KCNC2: potassium voltage-gated channel, Shaw-related subfamily, member 2
829NNNNicardipine hydrochloride
KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 50.40425Diltiazem hydrochloride
0.48532KCNA4: potassium voltage-gated channel, shaker-related subfamily, member 4
830NNNPenicillin G procaine
CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit0.47676Diltiazem malate
0.011266GABRA5: gamma-aminobutyric acid (GABA) A receptor, alpha 5
831NNNFurosemide
GABRG30.32258Diazepam
0.40101GABRA6: gamma-aminobutyric acid (GABA) A receptor, alpha 6
832NNNMetocurine iodide
KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 10.67619Tubocurarine chloride
0.016970CHRNA2
833NNNGallopamil hydrochloride
KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 50.86486Verapamil
0.019162CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
834NNNDiazoxide
SCN10A: sodium channel, voltage-gated, type X, alpha subunit0.40000Zonisamide
0.025826KCNS2: potassium voltage-gated channel, delayed-rectifier, subfamily S, member 2
835NNNVerapamil hydrochloride
KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 40.97059Verapamil
0.047460KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
836NNNBupivacaine hydrochloride
KCNA4: potassium voltage-gated channel, shaker-related subfamily, member 40.25532Nicardipine hydrochloride
0.48532KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5
837NNNPrilocaine hydrochloride
KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 50.53846Bupivacaine hydrochloride
0.026637KCNK5: potassium channel, subfamily K, member 5
838NNNIbutilide fumarate
KCNK10: potassium channel, subfamily K, member 100.29167Verapamil
0.18687KCNK1: potassium channel, subfamily K, member 1
839NNNZonisamide
PKD1: polycystic kidney disease 1 (autosomal dominant)0.22222Phenytoin
0.012238SCN1B: sodium channel, voltage-gated, type I, beta
840NNNSertraline
SLC6A1: solute carrier family 6 (neurotransmitter transporter, GABA), member 10.27273Cocaine
0.41406SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
841NNNMethoxyflurane
KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 40.66667Halothane
0.048992KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
842NNNDizocilpine maleate
KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 30.48387Nortriptyline hydrochloride
0.024221KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
843NNNAmiodarone hydrochloride
KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 60.42105Fluoxetine
0.021769KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
844NYYAmiodarone hydrochloride
KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 20.51744Halofantrine hydrochloride
0.019642KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
845NNNKetamine hydrochloride
GLRA30.39286Tropisetron hydrochloride
0.32591GABRA2: gamma-aminobutyric acid (GABA) A receptor, alpha 2
846NNNButabarbital
CHRNA3: cholinergic receptor, nicotinic, alpha 30.82353Pentobarbital
0.070568GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
847NNNGalantamine hydrobromide
HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A0.39394Granisetron hydrochloride
0.26265CHRNA10
848NNNPromethazine teoclate
RYR1: ryanodine receptor 1 (skeletal)0.40476Caffeine and sodium benzoate
0.0072515KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
849YNNDiazoxide
SCN3A: sodium channel, voltage-gated, type III, alpha subunit0.40000Zonisamide
0.025645KCNF1: potassium voltage-gated channel, subfamily F, member 1
850NNNDyclonine hydrochloride
KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 10.43333Tolazamide
0.021462KCNK5: potassium channel, subfamily K, member 5
851NNNKainic acid hydrate
GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A0.28125Dizocilpine maleate
0.096106GRIK2: glutamate receptor, ionotropic, kainate 2
852NNNHalothane
GRIA2: glutamate receptor, ionotropic, AMPA 20.22222Riluzole
0.69656GRIA1: glutamate receptor, ionotropic, AMPA 1
853NNNDizocilpine maleate
GRIK2: glutamate receptor, ionotropic, kainate 20.28125Kainic acid hydrate
0.15526GRIN1: glutamate receptor, ionotropic, N-methyl D-aspartate 1
854NNNFlurazepam
SCN10A: sodium channel, voltage-gated, type X, alpha subunit0.43750Chloroprocaine hydrochloride
0.012903GABRG2: gamma-aminobutyric acid (GABA) A receptor, gamma 2
855NNNSumatriptan
KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 10.40741Tolbutamide
0.021953HTR3E: 5-hydroxytryptamine (serotonin) receptor 3, family member E
856NNNAmlodipine maleate
CACNA2D4: calcium channel, voltage-dependent, alpha 2/delta subunit 40.48837Nisoldipine
0.0092209CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
857NNNDesflurane
GABRA5: gamma-aminobutyric acid (GABA) A receptor, alpha 51Isoflurane
0.69495GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
858NNYFlecainide acetate
KCND3: potassium voltage-gated channel, Shal-related subfamily, member 30.34146Bupivacaine hydrochloride
0.24349KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
859NNNDizocilpine maleate
KCNJ5: potassium inwardly-rectifying channel, subfamily J, member 50.23404Verapamil
0.70666KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
860NNNDiltiazem hydrochloride
KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 60.44444Fluoxetine
0.022791KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 2
861NNNCarbamazepine
CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit0.37037Phenytoin
0.13120SCN5A: sodium channel, voltage-gated, type V, alpha subunit
862NNNDiazoxide
P2RX5: purinergic receptor P2X, ligand-gated ion channel, 50.21739Caffeine
0.045889KCNE1L: KCNE1-like
863NNNProfenamine hydrochloride
SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 40.60714Trimipramine
0.010907GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A
864YYNHalazepam
GABRA2: gamma-aminobutyric acid (GABA) A receptor, alpha 20.76000Diazepam
0.74880GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
865NNNKainic acid hydrate
SLC6A14: solute carrier family 6 (amino acid transporter), member 140.33333Proline
0.015453GRIK4: glutamate receptor, ionotropic, kainate 4
866NNYPentobarbital calcium
GABRE0.40000Pentobarbital
0.33697GABRA6: gamma-aminobutyric acid (GABA) A receptor, alpha 6
867NNNSertraline
GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A0.42308Ketamine hydrochloride
0.010907SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
868NNNGallopamil hydrochloride
KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 10.86486Verapamil
0.010388CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
869NNNFluoxetine hydrochloride
KCNJ9: potassium inwardly-rectifying channel, subfamily J, member 90.33333Verapamil
0.68294KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
870NNNThioridazine hydrochloride
KCNJ9: potassium inwardly-rectifying channel, subfamily J, member 90.34091Verapamil
0.68294KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
871NNNIndapamide
KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 10.41026Glipizide
0.027394KCNQ1: potassium voltage-gated channel, KQT-like subfamily, member 1
872NNNFlecainide acetate
GLRA1: glycine receptor, alpha 10.25714Sevoflurane
0.019946KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 2
873NNNGabapentin
ACCN1: amiloride-sensitive cation channel 1, neuronal0.034483Amiloride hydrochloride
0.48895ACCN3: amiloride-sensitive cation channel 3
874NNNMethohexital
GABRA2: gamma-aminobutyric acid (GABA) A receptor, alpha 20.59091Pentobarbital
0.74880GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
875NNNGlyclopyramide
KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 20.37838Cisapride
0.014705KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11
876NNNRepaglinide
SCN5A: sodium channel, voltage-gated, type V, alpha subunit0.50000Moricizine
0.0099976KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
877NNNMibefradil dihydrochloride
SCN5A: sodium channel, voltage-gated, type V, alpha subunit0.44898Verapamil
0.13545CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
878NNNPromethazine teoclate
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.38636Flurazepam
0.016138KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
879NNNCodeine
CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)0.25000Nicotine
0.44784CHRNA2
880NNNPromethazine hydrochloride
KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 10.39024Dequalinium chloride
0.55275KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
881NNNHydroflumethiazide
GRIA1: glutamate receptor, ionotropic, AMPA 10.45833Riluzole
0.0091408KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 1
882NNNBupivacaine hydrochloride
KCND1: potassium voltage-gated channel, Shal-related subfamily, member 10.19355Diazoxide
0.62617KCND3: potassium voltage-gated channel, Shal-related subfamily, member 3
883NNNHalazepam
KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 30.48387Fluoxetine
0.016138GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
884NNNDiltiazem malate
KCNC3: potassium voltage-gated channel, Shaw-related subfamily, member 30.33962Verapamil
0.57702KCNC1: potassium voltage-gated channel, Shaw-related subfamily, member 1
885NNNNifedipine
SCN10A: sodium channel, voltage-gated, type X, alpha subunit0.38235Cocaine
0.13474CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
886NNNCaffeine
CLCN2: chloride channel 20.051282Lubiprostone
0.013935P2RX1: purinergic receptor P2X, ligand-gated ion channel, 1
887NNNTrichlormethiazide
GRIA1: glutamate receptor, ionotropic, AMPA 10.40000Riluzole
0.0091408KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 1
888NYNVerapamil hydrochloride
CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit0.97059Verapamil
0.10064CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
889NNNTrifluoperazine hydrochloride
GRIA1: glutamate receptor, ionotropic, AMPA 10.32353Riluzole
0.018721KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
890NNNRocuronium bromide
CHRNA4: cholinergic receptor, nicotinic, alpha 40.22368Codeine sulfate
0.52847CHRNA2
891NNNTrimipramine
GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A0.60714Profenamine hydrochloride
0.010907SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
892NNNThioridazine
KCNJ9: potassium inwardly-rectifying channel, subfamily J, member 90.34884Verapamil
0.68294KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
893NNNAmiloride hydrochloride
GRID2: glutamate receptor, ionotropic, delta 20.26923Riluzole
0.014175MCOLN1: mucolipin 1
894NNNGallopamil hydrochloride
KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 20.86486Verapamil
0.025006CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
895YNNTubocurarine chloride
GABRD: gamma-aminobutyric acid (GABA) A receptor, delta0.23975Midazolam
0.29568GABRA5: gamma-aminobutyric acid (GABA) A receptor, alpha 5
896NNNFelbamate
SCN10A: sodium channel, voltage-gated, type X, alpha subunit0.45000Benzocaine
0.010173GLRA2: glycine receptor, alpha 2
897NNNLoratadine
KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)0.32558Diltiazem hydrochloride
0.55487KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5
898NNNCaffeine
MCOLN1: mucolipin 10.14286Amiloride hydrochloride
0.023510P2RX1: purinergic receptor P2X, ligand-gated ion channel, 1
899NNNBupivacaine hydrochloride
KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 10.41935Tolazamide
0.39592KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
900NNNKainic acid hydrate
SLC6A7: solute carrier family 6 (neurotransmitter transporter, L-proline), member 70.33333Proline
0.012768GRIK4: glutamate receptor, ionotropic, kainate 4
901NNNPromethazine teoclate
KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 40.40476Caffeine and sodium benzoate
0.31077KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
902NNNMethyclothiazide
GRIA2: glutamate receptor, ionotropic, AMPA 20.57143Cyclothiazide
0.010212KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 1
903NNNCaffeine
TRPC6: transient receptor potential cation channel, subfamily C, member 60.14286Amiloride hydrochloride
0.016201P2RX5: purinergic receptor P2X, ligand-gated ion channel, 5
904NNNDiazoxide
P2RX3: purinergic receptor P2X, ligand-gated ion channel, 30.21739Caffeine
0.030341KCNE2: potassium voltage-gated channel, Isk-related family, member 2
905NNNGallopamil hydrochloride
SCN5A: sodium channel, voltage-gated, type V, alpha subunit0.86486Verapamil
0.11951CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
906NYNVerapamil hydrochloride
CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit0.97059Verapamil
0.13350CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
907NNNPenicillin G procaine
GABRG30.38776Flurazepam
0.40101GABRA6: gamma-aminobutyric acid (GABA) A receptor, alpha 6
908NNNProcainamide hydrochloride
CHRND: cholinergic receptor, nicotinic, delta0.72727Metoclopramide
0.012164SCN3A: sodium channel, voltage-gated, type III, alpha subunit
909NNNAminoglutethimide
CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit0.42105Ethosuximide
0.0080876CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)
910NNNDiazoxide
P2RX6: purinergic receptor P2X, ligand-gated ion channel, 60.21739Caffeine
0.029220KCNE3: potassium voltage-gated channel, Isk-related family, member 3
911NNNAmiodarone hydrochloride
KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 50.45000Propafenone hydrochloride
0.51877KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
912NNNHalazepam
KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)0.38461Diltiazem hydrochloride
0.019068GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
913NNNMepivacaine hydrochloride
KCND3: potassium voltage-gated channel, Shal-related subfamily, member 30.75000Bupivacaine hydrochloride
0.027135KCNK5: potassium channel, subfamily K, member 5
914NNNTrichlormethiazide
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.36667Furosemide
0.011447KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 1
915NNNRiluzole
CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit0.26923Amiloride hydrochloride
0.13386SCN5A: sodium channel, voltage-gated, type V, alpha subunit
916NNNBenzocaine
KCNK5: potassium channel, subfamily K, member 50.57895Procaine hydrochloride
0.025338SCN4B
917NNNAzimilide dihydrochloride
KCNE1: potassium voltage-gated channel, Isk-related family, member 10.21818Verapamil
0.026945KCNQ1: potassium voltage-gated channel, KQT-like subfamily, member 1
918NNNFlurazepam
KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)0.46154Diltiazem hydrochloride
0.019626GABRD: gamma-aminobutyric acid (GABA) A receptor, delta
919NNNProcainamide hydrochloride
CHRNB1: cholinergic receptor, nicotinic, beta 1 (muscle)0.72727Metoclopramide
0.013618SCN3A: sodium channel, voltage-gated, type III, alpha subunit
920NNNFluoxetine hydrochloride
GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 10.46875Halazepam
0.021675KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
921NNNEnoxacin hydrate
KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 20.30682Trifluoperazine maleate
0.021832GABRA3: gamma-aminobutyric acid (GABA) A receptor, alpha 3
922NNNCodeine phosphate
CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)0.16176Exemestane
0.44784CHRNA2
923NYNPrimidone
GABRA5: gamma-aminobutyric acid (GABA) A receptor, alpha 50.43478Ketamine hydrochloride
0.69495GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
924NNNEnoxacin hydrate
GABRG30.22500Flurazepam
0.40101GABRA6: gamma-aminobutyric acid (GABA) A receptor, alpha 6
925NNNQuinine hydrochloride hydrate
KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 100.31250Ketoconazole
0.53242KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
926NNNOxcarbazepine
KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 30.53846Desipramine hydrochloride
0.011391SCN5A: sodium channel, voltage-gated, type V, alpha subunit
927NNNDiazoxide
P2RX1: purinergic receptor P2X, ligand-gated ion channel, 10.21739Caffeine
0.045455KCNE3: potassium voltage-gated channel, Isk-related family, member 3
928NNNAmiodarone hydrochloride
KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 30.42105Fluoxetine
0.027535KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
929NNNVerapamil
GRIN2D: glutamate receptor, ionotropic, N-methyl D-aspartate 2D0.28261Haloperidol
0.029109KCNK4: potassium channel, subfamily K, member 4
930NNNMazindol
SLC6A7: solute carrier family 6 (neurotransmitter transporter, L-proline), member 70.076923Proline
0.41013SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
931NYYClobazam
GABRA2: gamma-aminobutyric acid (GABA) A receptor, alpha 20.78261Diazepam
0.74880GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
932NNNIbutilide fumarate
KCNK5: potassium channel, subfamily K, member 50.29167Verapamil
0.17161KCNK1: potassium channel, subfamily K, member 1
933NNNEthotoin
SCN4A: sodium channel, voltage-gated, type IV, alpha subunit0.36000Phenytoin
0.58238SCN5A: sodium channel, voltage-gated, type V, alpha subunit
934NNNTrifluoperazine hydrochloride
SCN5A: sodium channel, voltage-gated, type V, alpha subunit0.60526Moricizine hydrochloride
0.0087397KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
935NNNBepridil hydrochloride
KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 30.47059Desipramine hydrochloride
0.035737KCNQ4: potassium voltage-gated channel, KQT-like subfamily, member 4
936NNNDoxorubicin hydrochloride
SCN5A: sodium channel, voltage-gated, type V, alpha subunit0.30508Quinidine gluconate
0.0051579RYR1: ryanodine receptor 1 (skeletal)
937NNNDiazoxide
GRIN3B: glutamate receptor, ionotropic, N-methyl-D-aspartate 3B0.29167Ketamine hydrochloride
0.094588GRIA2: glutamate receptor, ionotropic, AMPA 2
938NNNPhencyclidine hydrochloride
GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A0.44444Dextromethorphan
0.015803CHRNA10
939NNNPropafenone hydrochloride
KCNK16: potassium channel, subfamily K, member 160.34091Verapamil
0.24672KCNK5: potassium channel, subfamily K, member 5
940NNNIndapamide
KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 110.43333Glyclopyramide
0.029070KCNE1: potassium voltage-gated channel, Isk-related family, member 1
941NNNAstemizole
KCNH6: potassium voltage-gated channel, subfamily H (eag-related), member 60.28846Verapamil
0.50037KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2
942NNNLoratadine
HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A0.56250Clozapine
0.017228KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5
943YNYCocaine
SCN2A: sodium channel, voltage-gated, type II, alpha subunit0.33333Procaine hydrochloride
0.60832SCN5A: sodium channel, voltage-gated, type V, alpha subunit
944NNNGabapentin
ACCN2: amiloride-sensitive cation channel 2, neuronal0.034483Amiloride hydrochloride
0.47336ACCN3: amiloride-sensitive cation channel 3
945NNNCodeine
KCNB2: potassium voltage-gated channel, Shab-related subfamily, member 20.38889Quinine hydrochloride hydrate
0.015233CHRNA3: cholinergic receptor, nicotinic, alpha 3
946NNNPenicillin G procaine
SCN10A: sodium channel, voltage-gated, type X, alpha subunit0.40476Procaine hydrochloride
0.011567GABRA2: gamma-aminobutyric acid (GABA) A receptor, alpha 2
947NNNPramoxine hydrochloride
KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 20.42105Cisapride
0.019783KCNK5: potassium channel, subfamily K, member 5
948NNNThioridazine
SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 20.53333Maprotiline
0.020826KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
949NNNCodeine
HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A0.35294Granisetron
0.26265CHRNA10
950NNYTocainide
SCN8A: sodium channel, voltage gated, type VIII, alpha subunit0.93333Tocainide hydrochloride
0.58865SCN5A: sodium channel, voltage-gated, type V, alpha subunit
951NNNKetoconazole
KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 20.37500Trifluoperazine hydrochloride
0.34677KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
952NNNVerapamil hydrochloride
CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit0.97059Verapamil
0.10383CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
953NNNCetiedil citrate
SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 20.31707Methylphenidate
0.022059KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
954NNNQuinine sulfate
CHRNA20.39744Codeine sulfate
0.017256KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
955YNNGlyburide
KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 20.45652Astemizole
0.015300KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
956NNNDofetilide
KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 110.41270Ibutilide fumarate
0.025318KCNK2: potassium channel, subfamily K, member 2
957NNNDesflurane
GABRA3: gamma-aminobutyric acid (GABA) A receptor, alpha 31Isoflurane
0.66731GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
958NNNBupivacaine hydrochloride
KCNC1: potassium voltage-gated channel, Shaw-related subfamily, member 10.34146Flecainide acetate
0.22153KCND3: potassium voltage-gated channel, Shal-related subfamily, member 3
959NNNVerapamil hydrochloride
KCND3: potassium voltage-gated channel, Shal-related subfamily, member 30.97059Verapamil
0.24349KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
960NNNPramoxine hydrochloride
SCN11A: sodium channel, voltage-gated, type XI, alpha subunit0.25714Cocaine
0.47691SCN10A: sodium channel, voltage-gated, type X, alpha subunit
961NNNBiperiden
CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)0.34615Nicotine
0.44784CHRNA2
962NNNHydrochlorothiazide
GRIA2: glutamate receptor, ionotropic, AMPA 20.64000Cyclothiazide
0.010212KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 1
963NNNHalazepam
KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 10.41667Bendroflumethiazide
0.011447GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
964NNNAmiloride hydrochloride
SCN3A: sodium channel, voltage-gated, type III, alpha subunit0.36000Lamotrigine
0.12915CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit
965NNNTolbutamide
SCN10A: sodium channel, voltage-gated, type X, alpha subunit0.45833Lidocaine
0.010834KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
966NNNPramoxine hydrochloride
SCN7A: sodium channel, voltage-gated, type VII, alpha0.30769Benzocaine
0.48453SCN9A: sodium channel, voltage-gated, type IX, alpha subunit
967NNNDibucaine
KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 20.40476Halofantrine hydrochloride
0.0091581SCN5A: sodium channel, voltage-gated, type V, alpha subunit
968NNNEthotoin
CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)0.52381Aminoglutethimide
0.0091480SCN5A: sodium channel, voltage-gated, type V, alpha subunit
969NNNAmiodarone hydrochloride
KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)0.38298Verapamil
0.59825KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
970NNNQuinine sulfate
SCN1A: sodium channel, voltage-gated, type I, alpha subunit1Quinidine sulfate
0.020008KCNB2: potassium voltage-gated channel, Shab-related subfamily, member 2
971NNNGalantamine hydrobromide
KCNB2: potassium voltage-gated channel, Shab-related subfamily, member 20.36111Quinine hydrochloride hydrate
0.015233CHRNA3: cholinergic receptor, nicotinic, alpha 3
972NNNPentobarbital
GLRA30.027027Tropisetron hydrochloride
0.32591GABRA2: gamma-aminobutyric acid (GABA) A receptor, alpha 2
973NNNGlyclopyramide
KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 10.32000Diazoxide
0.0097843KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11
974NNNDantrolene
KCNQ1: potassium voltage-gated channel, KQT-like subfamily, member 10.50000Azimilide dihydrochloride
0.0059674RYR1: ryanodine receptor 1 (skeletal)
975NNNRocuronium bromide
CHRNA3: cholinergic receptor, nicotinic, alpha 30.22368Codeine sulfate
0.52424CHRNA2
976NNNVerapamil
GRIN3B: glutamate receptor, ionotropic, N-methyl-D-aspartate 3B0.28261Haloperidol
0.026014KCNE1: potassium voltage-gated channel, Isk-related family, member 1
977NNNZonisamide
GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A0.29167Felbamate
0.022827SCN4B
978NNNCarbamazepine
CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit0.37037Phenytoin
0.13386SCN5A: sodium channel, voltage-gated, type V, alpha subunit
979NNNDizocilpine maleate
KCNJ9: potassium inwardly-rectifying channel, subfamily J, member 90.23404Verapamil
0.68294KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
980NNNDibucaine
SCN11A: sodium channel, voltage-gated, type XI, alpha subunit0.17500Cocaine
0.47691SCN10A: sodium channel, voltage-gated, type X, alpha subunit
981NNNCaffeine
KCNK12: potassium channel, subfamily K, member 120Halothane
0.019268P2RX6: purinergic receptor P2X, ligand-gated ion channel, 6
982YNNPrilocaine
SCN8A: sodium channel, voltage gated, type VIII, alpha subunit0.94118Prilocaine hydrochloride
0.58865SCN5A: sodium channel, voltage-gated, type V, alpha subunit
983NNNKetamine hydrochloride
GLRA1: glycine receptor, alpha 10.39286Tropisetron hydrochloride
0.32784GABRA2: gamma-aminobutyric acid (GABA) A receptor, alpha 2
984NNYBenzocaine
SCN9A: sodium channel, voltage-gated, type IX, alpha subunit0.57895Procaine hydrochloride
0.75410SCN3A: sodium channel, voltage-gated, type III, alpha subunit
985NNNDextromethorphan
SLC6A1: solute carrier family 6 (neurotransmitter transporter, GABA), member 10.35484Cocaine
0.41406SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
986NNNGallopamil hydrochloride
CHRNA20.36508Metocurine iodide
0.010362CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
987NNNChloroprocaine hydrochloride
SCN11A: sodium channel, voltage-gated, type XI, alpha subunit0.28125Cocaine
0.47691SCN10A: sodium channel, voltage-gated, type X, alpha subunit
988NNNNateglinide
HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A0.48387Granisetron
0.017658KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
989NNNPrimidone
CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)0.57143Aminoglutethimide
0.090264GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
990NNNAmiloride hydrochloride
SCN4A: sodium channel, voltage-gated, type IV, alpha subunit0.36000Lamotrigine
0.11479CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit
991NNNGlimepiride
CFTR: cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49)0.55814Glyburide
0.014445KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
992NNNBiperiden
SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 20.36364Cocaine
0.020712CHRNA2
993NNNBenzocaine
SCN11A: sodium channel, voltage-gated, type XI, alpha subunit0.36000Cocaine
0.47691SCN10A: sodium channel, voltage-gated, type X, alpha subunit
994NNNMaprotiline
HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A0.51852Mirtazapine
0.018814SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
995NNNProparacaine hydrochloride
SCN7A: sodium channel, voltage-gated, type VII, alpha0.36000Benzocaine
0.48453SCN9A: sodium channel, voltage-gated, type IX, alpha subunit
996NNNKainic acid hydrate
CLCN2: chloride channel 20.22857Lubiprostone
0.012355GRIK4: glutamate receptor, ionotropic, kainate 4
997NNNPrilocaine
KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 10.47826Tolbutamide
0.0099976SCN5A: sodium channel, voltage-gated, type V, alpha subunit
998NNYTocainide
SCN9A: sodium channel, voltage-gated, type IX, alpha subunit0.93333Tocainide hydrochloride
0.59648SCN5A: sodium channel, voltage-gated, type V, alpha subunit
999NNNGallopamil hydrochloride
KCNC1: potassium voltage-gated channel, Shaw-related subfamily, member 10.86486Verapamil
0.025943CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
1000NNNSertraline
HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A0.53571Clozapine
0.013198SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4